,date,title,url
0,2000-02-16,西南药业年报,/disclosure/listedinfo/announcement/c/600666_1999_0.pdf
1,2000-08-09,西南药业半年报,/disclosure/listedinfo/announcement/c/600666_2000_1.pdf
2,2001-03-14,西南药业年报,/disclosure/listedinfo/announcement/c/600666_2000_0.pdf
3,2001-05-16,西南药业上市公司章程,/disclosure/listedinfo/announcement/c/600666_2001_g.pdf
4,2001-08-17,西南药业半年报,/disclosure/listedinfo/announcement/c/600666_2001_1.pdf
5,2002-03-22,西南药业年报,/disclosure/listedinfo/announcement/c/600666_2001_n.pdf
6,2002-04-26,西南药业股东大会议事规则,/disclosure/listedinfo/announcement/c/600666_20020426_1.pdf
7,2002-04-26,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/600666_2002_1.pdf
8,2002-07-30,西南药业半年报,/disclosure/listedinfo/announcement/c/600666_2002_z.pdf
9,2002-10-31,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-31/600666_2002_3.pdf
10,2003-03-13,西南药业年报,/disclosure/listedinfo/announcement/c/2003-03-13/600666_2002_n.pdf
11,2003-04-16,西南药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-04-16/600666_20030416_1.pdf
12,2003-04-25,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-25/600666_2003_1.pdf
13,2003-06-19,西南药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-06-19/600666_20030619_1.pdf
14,2003-07-30,西南药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-07-30/600666_20030730_1.pdf
15,2003-07-30,西南药业半年报,/disclosure/listedinfo/announcement/c/2003-07-30/600666_2003_z.pdf
16,2003-08-30,西南药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-08-30/600666_20030830_1.pdf
17,2003-10-18,西南药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2003-10-18/600666_20031018_1.pdf
18,2003-10-18,西南药业募集资金使用管理办法,/disclosure/listedinfo/announcement/c/2003-10-18/600666_20031018_3.pdf
19,2003-10-18,西南药业关联交易公允决策制度,/disclosure/listedinfo/announcement/c/2003-10-18/600666_20031018_2.pdf
20,2003-10-18,西南药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2003-10-18/600666_20031018_4.pdf
21,2003-10-18,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-18/600666_2003_3.pdf
22,2004-02-10,西南药业年报,/disclosure/listedinfo/announcement/c/2004-02-10/600666_2003_n.pdf
23,2004-02-10,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-02-10/600666_20040210_2.pdf
24,2004-02-10,西南药业关联交易公告,/disclosure/listedinfo/announcement/c/2004-02-10/600666_20040210_3.pdf
25,2004-02-10,西南药业关联交易公告,/disclosure/listedinfo/announcement/c/2004-02-10/600666_20040210_4.pdf
26,2004-02-10,西南药业关联交易备查,/disclosure/listedinfo/announcement/c/2004-02-10/600666_20040210_5.pdf
27,2004-02-10,西南药业董事会决议公告暨召开股东大会通知,/disclosure/listedinfo/announcement/c/2004-02-10/600666_20040210_1.pdf
28,2004-02-19,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-02-19/600666_20040219_1.pdf
29,2004-03-13,西南药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-03-13/600666_20040313_1.pdf
30,2004-03-13,西南药业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-03-13/600666_20040313_2.pdf
31,2004-04-16,西南药业召开临时股东大会通知,/disclosure/listedinfo/announcement/c/2004-04-16/600666_20040416_4.pdf
32,2004-04-16,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-16/600666_20040416_2.pdf
33,2004-04-16,西南药业公告,/disclosure/listedinfo/announcement/c/2004-04-16/600666_20040416_3.pdf
34,2004-04-16,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-16/600666_20040416_1.pdf
35,2004-04-20,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-20/600666_2004_1.pdf
36,2004-05-19,西南药业2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-19/600666_20040519_1.pdf
37,2004-05-19,西南药业2004年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-05-19/600666_20040519_2.pdf
38,2004-07-14,西南药业配股审核未获通过公告,/disclosure/listedinfo/announcement/c/2004-07-14/600666_20040714_1.pdf
39,2004-07-24,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-07-24/600666_20040724_2.pdf
40,2004-07-24,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-07-24/600666_20040724_1.pdf
41,2004-07-24,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2004-07-24/600666_2004_zzy.pdf
42,2004-07-24,西南药业半年报,/disclosure/listedinfo/announcement/c/2004-07-24/600666_2004_z.pdf
43,2004-09-03,西南药业收购“葛兰素史克重庆公司”股权的公告,/disclosure/listedinfo/announcement/c/2004-09-03/600666_20040903_2.pdf
44,2004-09-03,西南药业关于重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2004-09-03/600666_20040903_3.pdf
45,2004-09-03,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-09-03/600666_20040903_1.pdf
46,2004-10-20,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-20/600666_2004_3.pdf
47,2004-11-30,西南药业关于股权被质押公告,/disclosure/listedinfo/announcement/c/2004-11-30/600666_20041130_1.pdf
48,2004-12-11,西南药业向银行借款的补充公告,/disclosure/listedinfo/announcement/c/2004-12-11/600666_20041211_1.pdf
49,2004-12-31,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-12-31/600666_20041231_2.pdf
50,2004-12-31,西南药业关于召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2004-12-31/600666_20041231_3.pdf
51,2004-12-31,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-12-31/600666_20041231_1.pdf
52,2005-01-07,西南药业关于巡回检查问题的整改报告,/disclosure/listedinfo/announcement/c/2005-01-07/600666_20050107_1.pdf
53,2005-02-01,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-02-01/600666_20050201_3.pdf
54,2005-02-01,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-02-01/600666_20050201_2.pdf
55,2005-02-01,西南药业2005年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-02-01/600666_20050201_1.pdf
56,2005-02-01,西南药业2005年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-02-01/600666_20050201_4.pdf
57,2005-03-17,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2005-03-17/600666_20050317_4.pdf
58,2005-03-17,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2005-03-17/600666_2004_nzy.pdf
59,2005-03-17,西南药业年报(修订版),/disclosure/listedinfo/announcement/c/2005-03-17/600666_2004_n.pdf
60,2005-03-17,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-17/600666_20050317_2.pdf
61,2005-03-17,西南药业关于召开2004年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2005-03-17/600666_20050317_3.pdf
62,2005-03-17,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-17/600666_20050317_1.pdf
63,2005-03-26,西南药业关于国有法人股股权质押的公告,/disclosure/listedinfo/announcement/c/2005-03-26/600666_20050326_1.pdf
64,2005-03-31,西南药业关于重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2005-03-31/600666_20050331_3.pdf
65,2005-03-31,西南药业关于为他人提供担保的补充公告,/disclosure/listedinfo/announcement/c/2005-03-31/600666_20050331_2.pdf
66,2005-03-31,西南药业关于2004年年度报告的补充公告,/disclosure/listedinfo/announcement/c/2005-03-31/600666_20050331_1.pdf
67,2005-04-16,西南药业提示性公告,/disclosure/listedinfo/announcement/c/2005-04-16/600666_20050416_1.pdf
68,2005-04-23,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-23/600666_20050423_2.pdf
69,2005-04-23,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-23/600666_2005_1.pdf
70,2005-04-23,西南药业2004年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-04-23/600666_20050423_1.pdf
71,2005-04-23,西南药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-04-23/600666_20050423_3.pdf
72,2005-06-01,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-06-01/600666_20050601_3.pdf
73,2005-06-01,西南药业关于召开2005年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2005-06-01/600666_20050601_2.pdf
74,2005-06-01,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-06-01/600666_20050601_1.pdf
75,2005-07-02,西南药业上市公司章程,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_g.pdf
76,2005-07-02,西南药业监事会议事规则,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_6.pdf
77,2005-07-02,西南药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_3.pdf
78,2005-07-02,西南药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_5.pdf
79,2005-07-02,西南药业董事会议事规则,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_4.pdf
80,2005-07-02,西南药业2005年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_1.pdf
81,2005-07-02,西南药业2005年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-07-02/600666_20050702_2.pdf
82,2005-08-06,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-06/600666_2005_zzy.pdf
83,2005-08-06,西南药业半年报,/disclosure/listedinfo/announcement/c/2005-08-06/600666_2005_z.pdf
84,2005-10-20,西南药业提示性公告,/disclosure/listedinfo/announcement/c/2005-10-20/600666_20051020_1.pdf
85,2005-10-20,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-20/600666_2005_3.pdf
86,2005-11-09,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-11-09/600666_20051109_2.pdf
87,2005-11-09,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-11-09/600666_20051109_1.pdf
88,2006-01-06,西南药业关联交易公告,/disclosure/listedinfo/announcement/c/2006-01-06/600666_20060106_2.pdf
89,2006-01-06,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-01-06/600666_20060106_1.pdf
90,2006-02-11,西南药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-02-11/600666_20060211_1.pdf
91,2006-02-17,西南药业关于延迟召开2006年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-02-17/600666_20060217_2.pdf
92,2006-02-17,西南药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-02-17/600666_20060217_1.pdf
93,2006-02-20,西南药业关于进行股权分置改革的提示性公告,/disclosure/listedinfo/announcement/c/2006-02-20/600666_20060220_1.pdf
94,2006-02-27,西南药业关于召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_1.pdf
95,2006-02-27,西南药业股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_4.pdf
96,2006-02-27,西南药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_3.pdf
97,2006-02-27,西南药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_2.pdf
98,2006-02-27,西南药业股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_5.pdf
99,2006-02-27,西南药业独立董事关于股权分置改革的独立意见函,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_6.pdf
100,2006-02-27,西南药业董事会关于股权分置改革相关股东会议的投票委托征集函,/disclosure/listedinfo/announcement/c/2006-02-27/600666_20060227_7.pdf
101,2006-03-06,西南药业董事会关于股权分置改革网上路演的通知,/disclosure/listedinfo/announcement/c/2006-03-06/600666_20060306_1.pdf
102,2006-03-08,西南药业关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-03-08/600666_20060308_1.pdf
103,2006-03-08,西南药业股权分置改革之补充保荐意见书,/disclosure/listedinfo/announcement/c/2006-03-08/600666_20060308_4.pdf
104,2006-03-08,西南药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-03-08/600666_20060308_3.pdf
105,2006-03-08,西南药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-03-08/600666_20060308_2.pdf
106,2006-03-08,西南药业股权分置改革方案调整的独立董事意见函,/disclosure/listedinfo/announcement/c/2006-03-08/600666_20060308_6.pdf
107,2006-03-08,西南药业股权分置改革补充法律意见书,/disclosure/listedinfo/announcement/c/2006-03-08/600666_20060308_5.pdf
108,2006-03-13,西南药业关于召开股权分置改革相关股东会议的第一次提示公告,/disclosure/listedinfo/announcement/c/2006-03-13/600666_20060313_1.pdf
109,2006-03-21,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-21/600666_20060321_3.pdf
110,2006-03-21,西南药业2006年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-03-21/600666_20060321_1.pdf
111,2006-03-21,西南药业2006年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-03-21/600666_20060321_4.pdf
112,2006-03-21,西南药业2006年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-03-21/600666_20060321_2.pdf
113,2006-03-21,西南药业2006年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-03-21/600666_20060321_5.pdf
114,2006-03-22,西南药业关于股权分置改革方案获得国资委批复的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-22/600666_20060322_1.pdf
115,2006-03-23,西南药业关于召开股权分置改革相关股东会议的第二次提示公告,/disclosure/listedinfo/announcement/c/2006-03-23/600666_20060323_1.pdf
116,2006-03-29,西南药业相关股东会议法律意见书,/disclosure/listedinfo/announcement/c/2006-03-29/600666_20060329_2.pdf
117,2006-03-29,西南药业股权分置改革相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-03-29/600666_20060329_1.pdf
118,2006-04-01,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2006-04-01/600666_20060401_3.pdf
119,2006-04-01,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2006-04-01/600666_2005_nzy.pdf
120,2006-04-01,西南药业年报,/disclosure/listedinfo/announcement/c/2006-04-01/600666_2005_n.pdf
121,2006-04-01,西南药业控股股东及其他关联方资金占用的专项说明,/disclosure/listedinfo/announcement/c/2006-04-01/600666_20060401_5.pdf
122,2006-04-01,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-01/600666_20060401_4.pdf
123,2006-04-01,西南药业关于对外担保的补充公告,/disclosure/listedinfo/announcement/c/2006-04-01/600666_20060401_2.pdf
124,2006-04-01,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-01/600666_20060401_1.pdf
125,2006-04-04,西南药业关于国有法人股股权质押的公告,/disclosure/listedinfo/announcement/c/2006-04-04/600666_20060404_1.pdf
126,2006-04-07,西南药业股权分置改革实施公告,/disclosure/listedinfo/announcement/c/2006-04-07/600666_20060407_1.pdf
127,2006-04-15,G西药第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-15/600666_2006_1.pdf
128,2006-04-27,G西药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-27/600666_20060427_1.pdf
129,2006-04-28,G西药关于2005年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2006-04-28/600666_20060428_1.pdf
130,2006-05-11,G西药公司章程（2006修订）,/disclosure/listedinfo/announcement/c/2006-05-11/600666_20060511_g.pdf
131,2006-05-11,G西药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-11/600666_20060511_2.pdf
132,2006-05-11,G西药2005年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-05-11/600666_20060511_1.pdf
133,2006-05-11,G西药2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-05-11/600666_20060511_3.pdf
134,2006-06-07,G西药提供担保公告,/disclosure/listedinfo/announcement/c/2006-06-07/600666_20060607_2.pdf
135,2006-06-07,G西药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-06-07/600666_20060607_1.pdf
136,2006-06-17,G西药关于股权被冻结公告,/disclosure/listedinfo/announcement/c/2006-06-17/600666_20060617_1.pdf
137,2006-06-20,G西药2006年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-06-20/600666_20060620_1.pdf
138,2006-06-24,G西药2006年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-06-24/600666_20060624_1.pdf
139,2006-06-24,G西药2006年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-06-24/600666_20060624_2.pdf
140,2006-07-22,G西药日常关联交易公告,/disclosure/listedinfo/announcement/c/2006-07-22/600666_20060722_2.pdf
141,2006-07-22,G西药董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-07-22/600666_20060722_1.pdf
142,2006-07-22,G西药半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2006-07-22/600666_2006_zzy.pdf
143,2006-07-22,G西药半年报（修订版）,/disclosure/listedinfo/announcement/c/2006-07-22/600666_2006_z.pdf
144,2006-07-28,G西药2006年中期报告更正公告,/disclosure/listedinfo/announcement/c/2006-07-28/600666_20060728_1.pdf
145,2006-08-08,G西药2006年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-08-08/600666_20060808_1.pdf
146,2006-08-11,G西药2006年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-08-11/600666_20060811_1.pdf
147,2006-08-11,G西药2006年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-08-11/600666_20060811_2.pdf
148,2006-08-30,G西药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-08-30/600666_20060830_1.pdf
149,2006-09-08,G西药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-09-08/600666_20060908_1.pdf
150,2006-10-21,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-21/600666_2006_3.pdf
151,2007-03-13,西南药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-03-13/600666_20070313_1.pdf
152,2007-03-17,西南药业日常关联交易的公告,/disclosure/listedinfo/announcement/c/2007-03-17/600666_20070317_5.pdf
153,2007-03-17,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2007-03-17/600666_2006_nzy.pdf
154,2007-03-17,西南药业年报,/disclosure/listedinfo/announcement/c/2007-03-17/600666_2006_n.pdf
155,2007-03-17,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-17/600666_20070317_3.pdf
156,2007-03-17,西南药业关于召开2006年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-03-17/600666_20070317_4.pdf
157,2007-03-17,西南药业关于控股股东及其他关联方资金占用的专项说明,/disclosure/listedinfo/announcement/c/2007-03-17/600666_20070317_6.pdf
158,2007-03-17,西南药业对外担保公告,/disclosure/listedinfo/announcement/c/2007-03-17/600666_20070317_2.pdf
159,2007-03-17,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-17/600666_20070317_1.pdf
160,2007-04-03,西南药业2006年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-04-03/600666_20070403_1.pdf
161,2007-04-05,西南药业关于国有法人股股权质押的公告,/disclosure/listedinfo/announcement/c/2007-04-05/600666_20070405_1.pdf
162,2007-04-07,西南药业2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-04-07/600666_20070407_1.pdf
163,2007-04-07,西南药业2006年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-04-07/600666_20070407_2.pdf
164,2007-04-11,西南药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-04-11/600666_20070411_1.pdf
165,2007-04-20,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-20/600666_2007_1.pdf
166,2007-06-01,西南药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-01/600666_20070601_1.pdf
167,2007-06-06,西南药业股票异常波动公告,/disclosure/listedinfo/announcement/c/2007-06-06/600666_20070606_1.pdf
168,2007-06-13,西南药业关于股权被冻结公告,/disclosure/listedinfo/announcement/c/2007-06-13/600666_20070613_1.pdf
169,2007-06-21,西南药业2007年上半年度业绩预增公告,/disclosure/listedinfo/announcement/c/2007-06-21/600666_20070621_1.pdf
170,2007-06-30,西南药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-06-30/600666_20070630_3.pdf
171,2007-06-30,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-30/600666_20070630_2.pdf
172,2007-06-30,西南药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-06-30/600666_20070630_1.pdf
173,2007-07-27,西南药业2007年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-07-27/600666_20070727_1.pdf
174,2007-08-03,西南药业2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-08-03/600666_20070803_1.pdf
175,2007-08-03,西南药业2007年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-08-03/600666_20070803_2.pdf
176,2007-08-04,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-04/600666_20070804_2.pdf
177,2007-08-04,西南药业关于加强上市公司治理专项活动自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-08-04/600666_20070804_3.pdf
178,2007-08-04,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-08-04/600666_20070804_1.pdf
179,2007-08-04,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-04/600666_2007_zzy.pdf
180,2007-08-04,西南药业半年报,/disclosure/listedinfo/announcement/c/2007-08-04/600666_2007_z.pdf
181,2007-08-31,西南药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2007-08-31/600666_20070831_1.pdf
182,2007-09-04,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-09-04/600666_20070904_1.pdf
183,2007-10-10,西南药业2007年第三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2007-10-10/600666_20071010_1.pdf
184,2007-10-20,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-20/600666_2007_3.pdf
185,2007-11-03,西南药业专门委员会实施细则,/disclosure/listedinfo/announcement/c/2007-11-03/600666_20071103_4.pdf
186,2007-11-03,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-11-03/600666_20071103_3.pdf
187,2007-11-03,西南药业关于公司治理专项活动整改报告,/disclosure/listedinfo/announcement/c/2007-11-03/600666_20071103_2.pdf
188,2007-11-03,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-11-03/600666_20071103_1.pdf
189,2008-01-24,西南药业2007年度业绩预增公告,/disclosure/listedinfo/announcement/c/2008-01-24/600666_20080124_1.pdf
190,2008-01-31,西南药业关于土地过户办理进展情况的公告,/disclosure/listedinfo/announcement/c/2008-01-31/600666_20080131_1.pdf
191,2008-02-05,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-02-05/600666_20080205_2.pdf
192,2008-02-05,西南药业关于召开2008年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-02-05/600666_20080205_3.pdf
193,2008-02-05,西南药业董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2008-02-05/600666_20080205_4.pdf
194,2008-02-05,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-02-05/600666_20080205_1.pdf
195,2008-02-23,西南药业2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-02-23/600666_20080223_1.pdf
196,2008-02-29,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-02-29/600666_20080229_3.pdf
197,2008-02-29,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-02-29/600666_20080229_2.pdf
198,2008-02-29,西南药业2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-02-29/600666_20080229_1.pdf
199,2008-02-29,西南药业2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-02-29/600666_20080229_4.pdf
200,2008-03-07,西南药业关于国有法人股股权质押的公告,/disclosure/listedinfo/announcement/c/2008-03-07/600666_20080307_1.pdf
201,2008-03-15,西南药业日常关联交易的公告,/disclosure/listedinfo/announcement/c/2008-03-15/600666_20080315_3.pdf
202,2008-03-15,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2008-03-15/600666_2007_nzy.pdf
203,2008-03-15,西南药业年报,/disclosure/listedinfo/announcement/c/2008-03-15/600666_2007_n.pdf
204,2008-03-15,西南药业控股股东及其他关联方资金占用的专项说明,/disclosure/listedinfo/announcement/c/2008-03-15/600666_20080315_5.pdf
205,2008-03-15,西南药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-15/600666_20080315_2.pdf
206,2008-03-15,西南药业关于召开2007年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-03-15/600666_20080315_4.pdf
207,2008-03-15,西南药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-15/600666_20080315_1.pdf
208,2008-04-03,西南药业2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-04-03/600666_20080403_1.pdf
209,2008-04-09,西南药业2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-04-09/600666_20080409_1.pdf
210,2008-04-09,西南药业2007年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-04-09/600666_20080409_2.pdf
211,2008-04-19,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-19/600666_2008_1.pdf
212,2008-04-29,西南药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2008-04-29/600666_20080429_1.pdf
213,2008-05-14,西南药业公告,/disclosure/listedinfo/announcement/c/2008-05-14/600666_20080514_2.pdf
214,2008-05-14,西南药业2007年度资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2008-05-14/600666_20080514_1.pdf
215,2008-05-22,西南药业关于股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2008-05-22/600666_20080522_2.pdf
216,2008-05-22,西南药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2008-05-22/600666_20080522_1.pdf
217,2008-06-04,西南药业关于诉讼事项进展情况的公告,/disclosure/listedinfo/announcement/c/2008-06-04/600666_20080604_1.pdf
218,2008-08-02,西南药业监事会议事规则,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_6.pdf
219,2008-08-02,西南药业关于公司治理整改情况的报告,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_3.pdf
220,2008-08-02,西南药业关联方资金往来管理制度,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_7.pdf
221,2008-08-02,西南药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_4.pdf
222,2008-08-02,西南药业董事会议事规则,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_5.pdf
223,2008-08-02,西南药业第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_2.pdf
224,2008-08-02,西南药业第六届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-02/600666_20080802_1.pdf
225,2008-08-02,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-02/600666_2008_zzy.pdf
226,2008-08-02,西南药业半年报,/disclosure/listedinfo/announcement/c/2008-08-02/600666_2008_z.pdf
227,2008-08-07,西南药业关于股权质押的公告,/disclosure/listedinfo/announcement/c/2008-08-07/600666_20080807_1.pdf
228,2008-10-18,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-18/600666_2008_3.pdf
229,2008-10-18,西南药业第六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-18/600666_20081018_1.pdf
230,2008-12-03,西南药业第六届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2008-12-03/600666_20081203_2.pdf
231,2008-12-03,西南药业第六届董事会第六次会议决议公告及召开2008年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-12-03/600666_20081203_1.pdf
232,2008-12-11,西南药业第六届董事会第七次会议决议公告及召开2008年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-12-11/600666_20081211_1.pdf
233,2008-12-11,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2008-12-11/600666_20081211_2.pdf
234,2008-12-23,西南药业2008年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-12-23/600666_20081223_2.pdf
235,2008-12-23,西南药业2008年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-12-23/600666_20081223_1.pdf
236,2008-12-27,西南药业监事会议事规则,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_5.pdf
237,2008-12-27,西南药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_6.pdf
238,2008-12-27,西南药业公司章程（2008修订）,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_g.pdf
239,2008-12-27,西南药业董事会议事规则,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_7.pdf
240,2008-12-27,西南药业2008年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_2.pdf
241,2008-12-27,西南药业2008年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_4.pdf
242,2008-12-27,西南药业2008年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_1.pdf
243,2008-12-27,西南药业2008年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-12-27/600666_20081227_3.pdf
244,2009-02-19,西南药业第六届董事会第八次会议决议公告及召开2009年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-02-19/600666_20090219_1.pdf
245,2009-02-19,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2009-02-19/600666_20090219_2.pdf
246,2009-02-26,西南药业第六届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2009-02-26/600666_20090226_1.pdf
247,2009-03-05,西南药业2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-05/600666_20090305_1.pdf
248,2009-03-11,西南药业股权质押的公告,/disclosure/listedinfo/announcement/c/2009-03-11/600666_20090311_1.pdf
249,2009-03-12,西南药业2009年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-12/600666_20090312_1.pdf
250,2009-03-12,西南药业2009年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-03-12/600666_20090312_2.pdf
251,2009-03-14,西南药业审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2009-03-14/600666_20090314_6.pdf
252,2009-03-14,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2009-03-14/600666_2008_nzy.pdf
253,2009-03-14,西南药业年报,/disclosure/listedinfo/announcement/c/2009-03-14/600666_2008_n.pdf
254,2009-03-14,西南药业控股股东及其他关联方资金占用的专项说明,/disclosure/listedinfo/announcement/c/2009-03-14/600666_20090314_5.pdf
255,2009-03-14,西南药业关于召开2008年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-14/600666_20090314_3.pdf
256,2009-03-14,西南药业关于公司日常关联交易的公告,/disclosure/listedinfo/announcement/c/2009-03-14/600666_20090314_2.pdf
257,2009-03-14,西南药业第六届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-14/600666_20090314_4.pdf
258,2009-03-14,西南药业第六届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-14/600666_20090314_1.pdf
259,2009-03-25,西南药业第六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-25/600666_20090325_1.pdf
260,2009-04-01,西南药业第六届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-01/600666_20090401_1.pdf
261,2009-04-03,西南药业2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-04-03/600666_20090403_1.pdf
262,2009-04-11,西南药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-04-11/600666_20090411_g.pdf
263,2009-04-11,西南药业2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-04-11/600666_20090411_1.pdf
264,2009-04-11,西南药业2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-04-11/600666_20090411_2.pdf
265,2009-04-18,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-18/600666_2009_1.pdf
266,2009-04-18,西南药业第六届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-18/600666_20090418_1.pdf
267,2009-04-22,西南药业股权质押的公告,/disclosure/listedinfo/announcement/c/2009-04-22/600666_20090422_1.pdf
268,2009-04-30,西南药业第六届董事会第十四次会议决议公告暨召开2009年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-04-30/600666_20090430_1.pdf
269,2009-05-07,西南药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2009-05-07/600666_20090507_1.pdf
270,2009-05-19,西南药业2009年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-05-19/600666_20090519_1.pdf
271,2009-05-23,西南药业2009年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-05-23/600666_20090523_1.pdf
272,2009-05-23,西南药业2009年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-05-23/600666_20090523_2.pdf
273,2009-06-04,西南药业关于诉讼事项进展情况的公告,/disclosure/listedinfo/announcement/c/2009-06-04/600666_20090604_1.pdf
274,2009-07-16,西南药业第六届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2009-07-16/600666_20090716_1.pdf
275,2009-08-01,西南药业第六届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-01/600666_20090801_2.pdf
276,2009-08-01,西南药业第六届董事会第十六次会议决议公告暨召开2009年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-08-01/600666_20090801_1.pdf
277,2009-08-01,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-01/600666_2009_zzy.pdf
278,2009-08-01,西南药业半年报,/disclosure/listedinfo/announcement/c/2009-08-01/600666_2009_z.pdf
279,2009-08-18,西南药业2009年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-08-18/600666_20090818_1.pdf
280,2009-08-22,西南药业第六届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-22/600666_20090822_2.pdf
281,2009-08-22,西南药业2009年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-08-22/600666_20090822_1.pdf
282,2009-08-22,西南药业2009年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-08-22/600666_20090822_3.pdf
283,2009-08-28,西南药业关于公司产品进入《国家基本药物目录》的提示性公告,/disclosure/listedinfo/announcement/c/2009-08-28/600666_20090828_1.pdf
284,2009-08-31,西南药业关于股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2009-08-31/600666_20090831_1.pdf
285,2009-09-19,西南药业第六届董事会第十八次会议决议公告暨召开2009年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-09-19/600666_20090919_1.pdf
286,2009-09-19,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2009-09-19/600666_20090919_2.pdf
287,2009-10-13,西南药业2009年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-10-13/600666_20091013_1.pdf
288,2009-10-17,西南药业公司章程,/disclosure/listedinfo/announcement/c/2009-10-17/600666_20091017_g.pdf
289,2009-10-17,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-17/600666_2009_3.pdf
290,2009-10-17,西南药业第六届监事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2009-10-17/600666_20091017_2.pdf
291,2009-10-17,西南药业2009年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-10-17/600666_20091017_1.pdf
292,2009-10-17,西南药业2009年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-10-17/600666_20091017_3.pdf
293,2009-10-24,西南药业第六届董事会第二十次会议决议公告暨召开2009年第五次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-10-24/600666_20091024_1.pdf
294,2009-11-13,西南药业2009年第五次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-11-13/600666_20091113_1.pdf
295,2009-11-17,西南药业第六届董事会第二十一次会议决议公告暨召开2009年第六次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-11-17/600666_20091117_1.pdf
296,2009-11-17,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2009-11-17/600666_20091117_2.pdf
297,2009-11-19,西南药业2009年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-11-19/600666_20091119_1.pdf
298,2009-11-19,西南药业2009年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-11-19/600666_20091119_2.pdf
299,2009-12-03,西南药业第六届董事会第二十二次会议决议公告暨召开2009年第七次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-12-03/600666_20091203_1.pdf
300,2009-12-03,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2009-12-03/600666_20091203_2.pdf
301,2009-12-08,西南药业2009年第六次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-12-08/600666_20091208_1.pdf
302,2009-12-12,西南药业第六届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2009-12-12/600666_20091212_2.pdf
303,2009-12-12,西南药业2009年第六次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-12-12/600666_20091212_1.pdf
304,2009-12-12,西南药业2009年第六次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-12-12/600666_20091212_3.pdf
305,2009-12-19,西南药业2009年第七次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-12-19/600666_20091219_1.pdf
306,2009-12-23,西南药业2009年第七次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-12-23/600666_20091223_1.pdf
307,2009-12-23,西南药业2009年第七次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-12-23/600666_20091223_2.pdf
308,2009-12-29,西南药业解除股权质押的公告,/disclosure/listedinfo/announcement/c/2009-12-29/600666_20091229_1.pdf
309,2010-01-30,西南药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-01-30/600666_20100130_2.pdf
310,2010-01-30,西南药业第六届董事会第二十四次会议决议公告暨召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-01-30/600666_20100130_1.pdf
311,2010-02-24,西南药业2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-02-24/600666_20100224_1.pdf
312,2010-02-27,西南药业2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-02-27/600666_20100227_1.pdf
313,2010-02-27,西南药业2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-02-27/600666_20100227_2.pdf
314,2010-03-20,西南药业外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_7.pdf
315,2010-03-20,西南药业审计机构选聘及评价制度,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_9.pdf
316,2010-03-20,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_2.pdf
317,2010-03-20,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-20/600666_2009_nzy.pdf
318,2010-03-20,西南药业年报,/disclosure/listedinfo/announcement/c/2010-03-20/600666_2009_n.pdf
319,2010-03-20,西南药业内幕信息及知情人管理制度,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_8.pdf
320,2010-03-20,西南药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_6.pdf
321,2010-03-20,西南药业关于召开2009年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_4.pdf
322,2010-03-20,西南药业第六届监事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_5.pdf
323,2010-03-20,西南药业第六届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_1.pdf
324,2010-03-20,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2010-03-20/600666_20100320_3.pdf
325,2010-04-13,西南药业2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-13/600666_20100413_1.pdf
326,2010-04-17,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-17/600666_2010_1.pdf
327,2010-04-17,西南药业2010年半年度预增公告,/disclosure/listedinfo/announcement/c/2010-04-17/600666_20100417_2.pdf
328,2010-04-17,西南药业2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-17/600666_20100417_1.pdf
329,2010-04-17,西南药业2009年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-17/600666_20100417_3.pdf
330,2010-04-21,西南药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2010-04-21/600666_20100421_1.pdf
331,2010-05-26,西南药业第六届董事会第二十七次会议决议公告暨召开2010年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-05-26/600666_20100526_2.pdf
332,2010-05-26,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2010-05-26/600666_20100526_1.pdf
333,2010-06-04,西南药业解除股权质押的公告,/disclosure/listedinfo/announcement/c/2010-06-04/600666_20100604_1.pdf
334,2010-06-22,西南药业2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-06-22/600666_20100622_1.pdf
335,2010-06-26,西南药业2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-06-26/600666_20100626_1.pdf
336,2010-06-26,西南药业2010年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-06-26/600666_20100626_2.pdf
337,2010-07-15,西南药业2010年半年度业绩预告修正公告,/disclosure/listedinfo/announcement/c/2010-07-15/600666_20100715_1.pdf
338,2010-07-31,西南药业第六届监事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2010-07-31/600666_20100731_2.pdf
339,2010-07-31,西南药业第六届董事会第二十八次会议决议公告暨召开2010年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-07-31/600666_20100731_1.pdf
340,2010-07-31,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-07-31/600666_2010_zzy.pdf
341,2010-07-31,西南药业半年报,/disclosure/listedinfo/announcement/c/2010-07-31/600666_2010_z.pdf
342,2010-08-17,西南药业2010年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-08-17/600666_20100817_1.pdf
343,2010-08-21,西南药业股权质押的公告,/disclosure/listedinfo/announcement/c/2010-08-21/600666_20100821_2.pdf
344,2010-08-21,西南药业2010年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-08-21/600666_20100821_1.pdf
345,2010-08-21,西南药业2010年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-08-21/600666_20100821_3.pdf
346,2010-09-27,西南药业股权解押和质押的公告,/disclosure/listedinfo/announcement/c/2010-09-27/600666_20100927_1.pdf
347,2010-09-30,西南药业关联交易公告,/disclosure/listedinfo/announcement/c/2010-09-30/600666_20100930_2.pdf
348,2010-09-30,西南药业第六届董事会第二十九次会议决议公告暨召开2010年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-09-30/600666_20100930_1.pdf
349,2010-10-13,西南药业2010年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-10-13/600666_20101013_1.pdf
350,2010-10-20,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-20/600666_2010_3.pdf
351,2010-10-20,西南药业第六届监事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2010-10-20/600666_20101020_3.pdf
352,2010-10-20,西南药业第六届董事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2010-10-20/600666_20101020_2.pdf
353,2010-10-20,西南药业2010年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-10-20/600666_20101020_1.pdf
354,2010-10-20,西南药业2010年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-10-20/600666_20101020_4.pdf
355,2010-11-13,西南药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2010-11-13/600666_20101113_1.pdf
356,2010-11-18,西南药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2010-11-18/600666_20101118_1.pdf
357,2010-11-19,西南药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2010-11-19/600666_20101119_1.pdf
358,2010-11-26,西南药业第六届董事会第三十一次会议决议公告暨召开2010年第五次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-11-26/600666_20101126_1.pdf
359,2010-11-26,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2010-11-26/600666_20101126_2.pdf
360,2010-12-14,西南药业2010年第五次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-12-14/600666_20101214_1.pdf
361,2010-12-18,西南药业2010年第五次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-12-18/600666_20101218_1.pdf
362,2010-12-18,西南药业2010年第五次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-12-18/600666_20101218_2.pdf
363,2011-03-19,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_2.pdf
364,2011-03-19,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2011-03-19/600666_2010_nzy.pdf
365,2011-03-19,西南药业年报,/disclosure/listedinfo/announcement/c/2011-03-19/600666_2010_n.pdf
366,2011-03-19,西南药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_8.pdf
367,2011-03-19,西南药业关于召开2010年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_3.pdf
368,2011-03-19,西南药业关联交易公告,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_5.pdf
369,2011-03-19,西南药业第六届监事会第三十二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_6.pdf
370,2011-03-19,西南药业第六届董事会第三十二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_1.pdf
371,2011-03-19,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_4.pdf
372,2011-03-19,西南药业澄清公告,/disclosure/listedinfo/announcement/c/2011-03-19/600666_20110319_7.pdf
373,2011-04-12,西南药业2010年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-04-12/600666_20110412_1.pdf
374,2011-04-16,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-16/600666_2011_1.pdf
375,2011-04-16,西南药业第七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-16/600666_20110416_2.pdf
376,2011-04-16,西南药业2010年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-04-16/600666_20110416_1.pdf
377,2011-04-16,西南药业2010年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-04-16/600666_20110416_3.pdf
378,2011-05-10,西南药业2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-05-10/600666_20110510_1.pdf
379,2011-05-21,西南药业股东股份减持公告,/disclosure/listedinfo/announcement/c/2011-05-21/600666_20110521_1.pdf
380,2011-05-31,西南药业股权解押和质押的公告,/disclosure/listedinfo/announcement/c/2011-05-31/600666_20110531_1.pdf
381,2011-07-26,西南药业关于召开2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-07-26/600666_20110726_2.pdf
382,2011-07-26,西南药业第七届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-07-26/600666_20110726_1.pdf
383,2011-07-26,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-07-26/600666_2011_zzy.pdf
384,2011-07-26,西南药业半年报,/disclosure/listedinfo/announcement/c/2011-07-26/600666_2011_z.pdf
385,2011-08-13,西南药业2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-08-13/600666_20110813_1.pdf
386,2011-08-20,西南药业2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-08-20/600666_20110820_1.pdf
387,2011-08-20,西南药业2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-08-20/600666_20110820_2.pdf
388,2011-10-20,西南药业董事会秘书管理办法,/disclosure/listedinfo/announcement/c/2011-10-20/600666_20111020_2.pdf
389,2011-10-20,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-20/600666_2011_3.pdf
390,2011-10-20,西南药业第七届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-20/600666_20111020_1.pdf
391,2011-11-03,西南药业关于财政部驻重庆市财政监察专员办事处对公司会计信息质量检查情况的公告,/disclosure/listedinfo/announcement/c/2011-11-03/600666_20111103_1.pdf
392,2011-11-04,西南药业关于召开2011年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-11-04/600666_20111104_2.pdf
393,2011-11-04,西南药业第七届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2011-11-04/600666_20111104_1.pdf
394,2011-11-04,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2011-11-04/600666_20111104_3.pdf
395,2011-11-22,西南药业2011年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-11-22/600666_20111122_1.pdf
396,2011-11-26,西南药业内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2011-11-26/600666_20111126_4.pdf
397,2011-11-26,西南药业公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-11-26/600666_20111126_g.pdf
398,2011-11-26,西南药业第七届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-11-26/600666_20111126_2.pdf
399,2011-11-26,西南药业2011年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-11-26/600666_20111126_1.pdf
400,2011-11-26,西南药业2011年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-11-26/600666_20111126_3.pdf
401,2012-03-17,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_3.pdf
402,2012-03-17,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2012-03-17/600666_2011_nzy.pdf
403,2012-03-17,西南药业年报,/disclosure/listedinfo/announcement/c/2012-03-17/600666_2011_n.pdf
404,2012-03-17,西南药业内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_9.pdf
405,2012-03-17,西南药业控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_7.pdf
406,2012-03-17,西南药业关于召开2011年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_5.pdf
407,2012-03-17,西南药业关于会计差错更正的公告,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_6.pdf
408,2012-03-17,西南药业独立董事2011年年度述职报告,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_8.pdf
409,2012-03-17,西南药业第七届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_2.pdf
410,2012-03-17,西南药业第七届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_1.pdf
411,2012-03-17,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2012-03-17/600666_20120317_4.pdf
412,2012-04-10,西南药业2011年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-04-10/600666_20120410_1.pdf
413,2012-04-14,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-14/600666_2012_1.pdf
414,2012-04-14,西南药业2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-14/600666_20120414_1.pdf
415,2012-04-14,西南药业2011年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-04-14/600666_20120414_2.pdf
416,2012-05-30,西南药业关于公司胶囊剂药品检测情况及处置措施的公告,/disclosure/listedinfo/announcement/c/2012-05-30/600666_20120530_1.pdf
417,2012-07-05,西南药业第七届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2012-07-05/600666_20120705_1.pdf
418,2012-07-05,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2012-07-05/600666_20120705_2.pdf
419,2012-07-20,西南药业2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-07-20/600666_20120720_1.pdf
420,2012-07-26,西南药业关于召开2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-07-26/600666_20120726_3.pdf
421,2012-07-26,西南药业第七届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2012-07-26/600666_20120726_2.pdf
422,2012-07-26,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-07-26/600666_2012_zzy.pdf
423,2012-07-26,西南药业半年报,/disclosure/listedinfo/announcement/c/2012-07-26/600666_2012_z.pdf
424,2012-07-26,西南药业2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-07-26/600666_20120726_1.pdf
425,2012-07-26,西南药业2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-07-26/600666_20120726_4.pdf
426,2012-08-14,西南药业2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-08-14/600666_20120814_1.pdf
427,2012-08-18,西南药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-08-18/600666_20120818_g.pdf
428,2012-08-18,西南药业2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-08-18/600666_20120818_1.pdf
429,2012-08-18,西南药业2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-08-18/600666_20120818_2.pdf
430,2012-08-30,西南药业关于召开2012年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-08-30/600666_20120830_3.pdf
431,2012-08-30,西南药业关于未来三年（2012-2014年度）股东分红回报规划的公告,/disclosure/listedinfo/announcement/c/2012-08-30/600666_20120830_2.pdf
432,2012-08-30,西南药业第七届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-30/600666_20120830_1.pdf
433,2012-09-21,西南药业关于参加“重庆辖区上市公司投资者网上集体接待日主题活动”的公告,/disclosure/listedinfo/announcement/c/2012-09-21/600666_20120921_1.pdf
434,2012-10-16,西南药业2012年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-10-16/600666_20121016_1.pdf
435,2012-10-20,西南药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-10-20/600666_20121020_g.pdf
436,2012-10-20,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-20/600666_2012_3.pdf
437,2012-10-20,西南药业第七届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-20/600666_20121020_2.pdf
438,2012-10-20,西南药业2012年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-10-20/600666_20121020_1.pdf
439,2012-10-20,西南药业2012年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-10-20/600666_20121020_3.pdf
440,2013-03-20,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_5.pdf
441,2013-03-20,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2013-03-19/600666_2012_nzy.pdf
442,2013-03-20,西南药业年报,/disclosure/listedinfo/announcement/c/2013-03-19/600666_2012_n.pdf
443,2013-03-20,西南药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_11.pdf
444,2013-03-20,西南药业关于利润分配等事项的独立董事意见,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_8.pdf
445,2013-03-20,西南药业非经营性资金占用及其他关联资金往来情况汇总表,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_14.pdf
446,2013-03-20,西南药业非经营性资金占用及其他关联资金往来情况汇总表,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_13.pdf
447,2013-03-20,西南药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_12.pdf
448,2013-03-20,西南药业独立董事对公司对外担保的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_7.pdf
449,2013-03-20,西南药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_9.pdf
450,2013-03-20,西南药业第七届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_4.pdf
451,2013-03-20,西南药业第七届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_3.pdf
452,2013-03-20,西南药业担保事项公告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_6.pdf
453,2013-03-20,西南药业2012年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_10.pdf
454,2013-03-20,西南药业2012年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2013-03-19/600666_20130320_15.pdf
455,2013-03-21,西南药业关于召开2012年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-03-20/600666_20130321_2.pdf
456,2013-03-21,西南药业关于公司产品进入《国家基本药物目录》的提示性公告,/disclosure/listedinfo/announcement/c/2013-03-20/600666_20130321_3.pdf
457,2013-04-02,西南药业相关事项独立董事意见,/disclosure/listedinfo/announcement/c/2013-04-01/600666_20130402_3.pdf
458,2013-04-02,西南药业第七届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-01/600666_20130402_2.pdf
459,2013-04-02,西南药业第七届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-01/600666_20130402_1.pdf
460,2013-04-03,西南药业关于召开2012年度现金分红专项说明会的通知,/disclosure/listedinfo/announcement/c/2013-04-02/600666_20130403_1.pdf
461,2013-04-09,西南药业2012年度现金分红专项说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2013-04-08/600666_20130409_1.pdf
462,2013-04-09,西南药业2012年度现金分红说明会召开情况的公告附件,/disclosure/listedinfo/announcement/c/2013-04-08/600666_20130409_2.pdf
463,2013-04-10,西南药业2012年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-04-09/600666_20130410_1.pdf
464,2013-04-13,西南药业关于2012年年度股东大会网络投票的提示性公告,/disclosure/listedinfo/announcement/c/2013-04-12/600666_20130413_1.pdf
465,2013-04-17,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-04-16/600666_20130417_5.pdf
466,2013-04-17,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-16/600666_2013_1.pdf
467,2013-04-17,西南药业第七届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-16/600666_20130417_3.pdf
468,2013-04-17,西南药业2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-04-16/600666_20130417_6.pdf
469,2013-04-17,西南药业2012年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-04-16/600666_20130417_7.pdf
470,2013-04-27,西南药业关于召开2013年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-04-26/600666_20130427_3.pdf
471,2013-04-27,西南药业关于受让股权的关联交易公告,/disclosure/listedinfo/announcement/c/2013-04-26/600666_20130427_2.pdf
472,2013-04-27,西南药业关于受让股权的独立董事意见专用签章页,/disclosure/listedinfo/announcement/c/2013-04-26/600666_20130427_5.pdf
473,2013-04-27,西南药业关于受让股权的独立董事意见,/disclosure/listedinfo/announcement/c/2013-04-26/600666_20130427_4.pdf
474,2013-04-27,西南药业第七届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-26/600666_20130427_1.pdf
475,2013-05-10,西南药业澄清公告,/disclosure/listedinfo/announcement/c/2013-05-09/600666_20130510_1.pdf
476,2013-05-14,西南药业澄清公告,/disclosure/listedinfo/announcement/c/2013-05-13/600666_20130514_1.pdf
477,2013-05-21,西南药业2013年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-05-20/600666_20130521_1.pdf
478,2013-05-25,西南药业2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-05-24/600666_20130525_1.pdf
479,2013-05-25,西南药业2013年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-05-24/600666_20130525_2.pdf
480,2013-05-30,西南药业2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-05-29/600666_20130530_1.pdf
481,2013-06-28,西南药业互保事项公告,/disclosure/listedinfo/announcement/c/2013-06-27/600666_20130628_2.pdf
482,2013-06-28,西南药业关于召开2013年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-06-27/600666_20130628_3.pdf
483,2013-06-28,西南药业关于互保事项的独立董事意见,/disclosure/listedinfo/announcement/c/2013-06-27/600666_20130628_4.pdf
484,2013-06-28,西南药业第七届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-27/600666_20130628_1.pdf
485,2013-07-09,西南药业2013年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-07-08/600666_20130709_1.pdf
486,2013-07-16,西南药业2013年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-07-15/600666_20130716_1.pdf
487,2013-07-16,西南药业2013年第二次临时股东大会的法律意见书签署页,/disclosure/listedinfo/announcement/c/2013-07-15/600666_20130716_2.pdf
488,2013-07-16,西南药业2013年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-07-15/600666_20130716_3.pdf
489,2013-07-27,西南药业关于召开2013年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-07-26/600666_20130727_2.pdf
490,2013-07-27,西南药业关于日常关联交易的公告,/disclosure/listedinfo/announcement/c/2013-07-26/600666_20130727_3.pdf
491,2013-07-27,西南药业关于日常关联交易的独立董事意见,/disclosure/listedinfo/announcement/c/2013-07-26/600666_20130727_5.pdf
492,2013-07-27,西南药业第七届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-07-26/600666_20130727_4.pdf
493,2013-07-27,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-07-26/600666_2013_zzy.pdf
494,2013-07-27,西南药业半年报,/disclosure/listedinfo/announcement/c/2013-07-26/600666_2013_z.pdf
495,2013-08-20,西南药业2013年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-08-19/600666_20130820_1.pdf
496,2013-08-24,西南药业2013年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-08-23/600666_20130824_1.pdf
497,2013-08-24,西南药业2013年第三次临时股东大会法律意见书签章页,/disclosure/listedinfo/announcement/c/2013-08-23/600666_20130824_3.pdf
498,2013-08-24,西南药业2013年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-08-23/600666_20130824_2.pdf
499,2013-10-22,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-21/600666_2013_3.pdf
500,2013-10-26,西南药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2013-10-25/600666_20131026_2.pdf
501,2013-10-26,西南药业股权解押和质押的公告,/disclosure/listedinfo/announcement/c/2013-10-25/600666_20131026_1.pdf
502,2013-12-13,西南药业关于召开2013年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-12-12/600666_20131213_2.pdf
503,2013-12-13,西南药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2013-12-12/600666_20131213_4.pdf
504,2013-12-13,西南药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-12-12/600666_20131213_3.pdf
505,2013-12-13,西南药业第七届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2013-12-12/600666_20131213_1.pdf
506,2013-12-25,西南药业2013年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-12-24/600666_20131225_1.pdf
507,2013-12-31,西南药业2013年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-12-30/600666_20131231_1.pdf
508,2013-12-31,西南药业2013年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-12-30/600666_20131231_2.pdf
509,2014-01-03,西南药业关于新版GMP认证进展情况的公告,/disclosure/listedinfo/announcement/c/2014-01-02/600666_20140103_1.pdf
510,2014-01-04,西南药业关于新版GMP认证进展情况的补充公告,/disclosure/listedinfo/announcement/c/2014-01-03/600666_20140104_1.pdf
511,2014-01-15,西南药业对外担保公告,/disclosure/listedinfo/announcement/c/2014-01-14/600666_20140115_1.pdf
512,2014-02-15,西南药业关于公司承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-14/600666_20140215_1.pdf
513,2014-02-18,西南药业对外担保公告,/disclosure/listedinfo/announcement/c/2014-02-17/600666_20140218_1.pdf
514,2014-02-22,西南药业关于新版GMP认证进入公示阶段的公告,/disclosure/listedinfo/announcement/c/2014-02-21/600666_20140222_1.pdf
515,2014-03-06,西南药业关于公司董事、高管辞职的公告,/disclosure/listedinfo/announcement/c/2014-03-05/600666_20140306_1.pdf
516,2014-03-15,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_3.pdf
517,2014-03-15,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2014-03-14/600666_2013_nzy.pdf
518,2014-03-15,西南药业年报,/disclosure/listedinfo/announcement/c/2014-03-14/600666_2013_n.pdf
519,2014-03-15,西南药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_14.pdf
520,2014-03-15,西南药业关于召开2013年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_1.pdf
521,2014-03-15,西南药业关于新版GMP认证进展的公告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_17.pdf
522,2014-03-15,西南药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_11.pdf
523,2014-03-15,西南药业对外担保事项公告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_2.pdf
524,2014-03-15,西南药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_7.pdf
525,2014-03-15,西南药业独立董事关于对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_9.pdf
526,2014-03-15,西南药业独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_12.pdf
527,2014-03-15,西南药业第七届监事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_5.pdf
528,2014-03-15,西南药业第七届董事会审计委员会2013年履职情况报告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_16.pdf
529,2014-03-15,西南药业第七届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_4.pdf
530,2014-03-15,西南药业2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_10.pdf
531,2014-03-15,西南药业2013年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2014-03-14/600666_20140315_13.pdf
532,2014-03-20,西南药业关于通过新版GMP认证的公告,/disclosure/listedinfo/announcement/c/2014-03-19/600666_20140320_1.pdf
533,2014-04-02,西南药业关于召开2013年度网上业绩说明会的公告,/disclosure/listedinfo/announcement/c/2014-04-01/600666_20140402_1.pdf
534,2014-04-05,西南药业关于2013年度网上业绩说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2014-04-04/600666_20140405_1.pdf
535,2014-04-05,西南药业2013年度网上业绩说明会会议纪要,/disclosure/listedinfo/announcement/c/2014-04-04/600666_20140405_2.pdf
536,2014-04-11,西南药业关于2013年年度股东大会网络投票的提示性公告,/disclosure/listedinfo/announcement/c/2014-04-10/600666_20140411_1.pdf
537,2014-04-15,西南药业2013年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-04-14/600666_20140415_1.pdf
538,2014-04-18,西南药业2013年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-04-17/600666_20140418_1.pdf
539,2014-04-18,西南药业2013年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-04-17/600666_20140418_2.pdf
540,2014-04-19,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-18/600666_2014_1.pdf
541,2014-04-26,西南药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2014-04-25/600666_20140426_1.pdf
542,2014-04-30,西南药业关于公司董事、监事辞职的公告,/disclosure/listedinfo/announcement/c/2014-04-29/600666_20140430_1.pdf
543,2014-05-06,西南药业重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2014-05-05/600666_20140506_1.pdf
544,2014-05-13,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-05-12/600666_20140513_1.pdf
545,2014-05-13,西南药业关于2013年年报事后审核意见的回复公告,/disclosure/listedinfo/announcement/c/2014-05-12/600666_20140513_2.pdf
546,2014-05-15,西南药业关于召开2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-05-14/600666_20140515_3.pdf
547,2014-05-15,西南药业对外担保公告,/disclosure/listedinfo/announcement/c/2014-05-14/600666_20140515_4.pdf
548,2014-05-15,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-05-14/600666_20140515_5.pdf
549,2014-05-15,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-05-14/600666_20140515_6.pdf
550,2014-05-15,西南药业第七届监事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-14/600666_20140515_2.pdf
551,2014-05-15,西南药业第七届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-14/600666_20140515_1.pdf
552,2014-05-20,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-05-19/600666_20140520_1.pdf
553,2014-05-24,西南药业2014年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-23/600666_20140524_1.pdf
554,2014-05-27,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-05-26/600666_20140527_1.pdf
555,2014-05-31,西南药业2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-30/600666_20140531_1.pdf
556,2014-05-31,西南药业2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-30/600666_20140531_2.pdf
557,2014-06-04,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-03/600666_20140604_1.pdf
558,2014-06-05,西南药业重大资产重组延长停牌期的公告,/disclosure/listedinfo/announcement/c/2014-06-04/600666_20140605_1.pdf
559,2014-06-09,西南药业2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-06-08/600666_20140609_2.pdf
560,2014-06-12,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-11/600666_20140612_1.pdf
561,2014-06-19,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-18/600666_20140619_1.pdf
562,2014-06-26,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-06-25/600666_20140626_1.pdf
563,2014-07-03,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-02/600666_20140703_1.pdf
564,2014-07-05,西南药业重大资产重组延长停牌期的公告,/disclosure/listedinfo/announcement/c/2014-07-04/600666_20140705_1.pdf
565,2014-07-12,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-11/600666_20140712_1.pdf
566,2014-07-19,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-18/600666_20140719_1.pdf
567,2014-07-24,西南药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-07-23/600666_2014_zzy.pdf
568,2014-07-24,西南药业半年报,/disclosure/listedinfo/announcement/c/2014-07-23/600666_2014_z.pdf
569,2014-07-26,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-07-25/600666_20140726_1.pdf
570,2014-08-02,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-08-01/600666_20140802_1.pdf
571,2014-08-06,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-08-05/600666_20140806_1.pdf
572,2014-08-12,西南药业重大资产重组复牌公告,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_1.pdf
573,2014-08-12,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易预案（摘要）,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_4.pdf
574,2014-08-12,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易预案,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_7.pdf
575,2014-08-12,西南药业独立董事关于公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_8.pdf
576,2014-08-12,西南药业第七届监事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_3.pdf
577,2014-08-12,西南药业第七届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_2.pdf
578,2014-08-12,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易预案之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_5.pdf
579,2014-08-12,西南药业：海通证券股份有限公司对《西南药业股份有限公司关于停牌前股票价格波动未达到“128号文”第五条相关标准的说明》之核查意见,/disclosure/listedinfo/announcement/c/2014-08-11/600666_20140812_6.pdf
580,2014-08-13,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易预案（修订版）,/disclosure/listedinfo/announcement/c/2014-08-12/600666_20140813_2.pdf
581,2014-08-13,西南药业关于左洪波、褚淑霞除哈尔滨奥瑞德光电技术股份有限公司以外其他对外投资情况的公告,/disclosure/listedinfo/announcement/c/2014-08-12/600666_20140813_1.pdf
582,2014-08-14,西南药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-08-13/600666_20140814_1.pdf
583,2014-08-19,西南药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-08-18/600666_20140819_1.pdf
584,2014-08-22,西南药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-08-21/600666_20140822_1.pdf
585,2014-08-27,西南药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-08-26/600666_20140827_1.pdf
586,2014-09-06,西南药业重大资产重组涉及的置出资产及负债项目资产评估报告书,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_14.pdf
587,2014-09-06,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书摘要（草案）,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_3.pdf
588,2014-09-06,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书（草案）,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_11.pdf
589,2014-09-06,西南药业收购报告书（摘要）,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_5.pdf
590,2014-09-06,西南药业审计报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_20.pdf
591,2014-09-06,西南药业募集资金使用管理制度,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_10.pdf
592,2014-09-06,西南药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_8.pdf
593,2014-09-06,西南药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_6.pdf
594,2014-09-06,西南药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_7.pdf
595,2014-09-06,西南药业关于召开2014年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_4.pdf
596,2014-09-06,西南药业独立董事关于公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_19.pdf
597,2014-09-06,西南药业第七届监事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_2.pdf
598,2014-09-06,西南药业第七届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_1.pdf
599,2014-09-06,西南药业备考审计报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_13.pdf
600,2014-09-06,西南药业备考合并盈利预测审核报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_17.pdf
601,2014-09-06,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_12.pdf
602,2014-09-06,西南药业：哈尔滨奥瑞德光电技术股份有限公司盈利预测审核报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_16.pdf
603,2014-09-06,西南药业：哈尔滨奥瑞德光电技术股份有限公司审计报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_18.pdf
604,2014-09-06,西南药业：哈尔滨奥瑞德光电技术股份有限公司拟借壳西南药业股份有限公司实现上市项目资产评估报告,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_21.pdf
605,2014-09-06,西南药业：北京国枫凯文律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_15.pdf
606,2014-09-06,西南药业：《重组报告书》与《重组预案》主要差异说明,/disclosure/listedinfo/announcement/c/2014-09-05/600666_20140906_9.pdf
607,2014-09-19,西南药业关于召开2014年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-09-18/600666_20140919_1.pdf
608,2014-09-19,西南药业2014年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-09-18/600666_20140919_2.pdf
609,2014-09-23,西南药业澄清公告,/disclosure/listedinfo/announcement/c/2014-09-22/600666_20140923_1.pdf
610,2014-09-24,西南药业2014年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-09-23/600666_20140924_1.pdf
611,2014-09-24,西南药业2014年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-23/600666_20140924_2.pdf
612,2014-10-09,西南药业关于收到中国证监会行政许可申请受理通知书的公告,/disclosure/listedinfo/announcement/c/2014-10-08/600666_20141009_1.pdf
613,2014-10-28,西南药业关于召开2014年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-10-27/600666_20141028_4.pdf
614,2014-10-28,西南药业关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2014-10-27/600666_20141028_5.pdf
615,2014-10-28,西南药业对外担保公告,/disclosure/listedinfo/announcement/c/2014-10-27/600666_20141028_3.pdf
616,2014-10-28,西南药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-27/600666_2014_3.pdf
617,2014-10-28,西南药业第七届监事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-27/600666_20141028_2.pdf
618,2014-10-28,西南药业第七届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-27/600666_20141028_1.pdf
619,2014-11-04,西南药业关于收到中国证监会行政许可项目审查一次反馈意见通知书的公告,/disclosure/listedinfo/announcement/c/2014-11-03/600666_20141104_1.pdf
620,2014-11-07,西南药业关于召开2014年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-11-06/600666_20141107_1.pdf
621,2014-11-07,西南药业2014年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-11-06/600666_20141107_2.pdf
622,2014-11-13,西南药业关于设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2014-11-12/600666_20141113_4.pdf
623,2014-11-13,西南药业第七届监事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-11-12/600666_20141113_3.pdf
624,2014-11-13,西南药业第七届董事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-11-12/600666_20141113_2.pdf
625,2014-11-13,西南药业2014年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-11-12/600666_20141113_1.pdf
626,2014-11-13,西南药业2014年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-11-12/600666_20141113_5.pdf
627,2014-12-09,西南药业关于参加“重庆辖区上市公司投资者网上集体接待日主题活动”的公告,/disclosure/listedinfo/announcement/c/2014-12-08/600666_20141209_1.pdf
628,2014-12-10,西南药业关于申请延期回复中国证监会一次反馈意见的公告,/disclosure/listedinfo/announcement/c/2014-12-09/600666_20141210_1.pdf
629,2014-12-16,西南药业关于召开2014年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-12-15/600666_20141216_4.pdf
630,2014-12-16,西南药业对外担保公告,/disclosure/listedinfo/announcement/c/2014-12-15/600666_20141216_3.pdf
631,2014-12-16,西南药业第七届监事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-15/600666_20141216_2.pdf
632,2014-12-16,西南药业第七届董事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-15/600666_20141216_1.pdf
633,2014-12-23,西南药业关于重大资产重组获得商务部反垄断局函告的公告,/disclosure/listedinfo/announcement/c/2014-12-22/600666_20141223_1.pdf
634,2014-12-23,西南药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-12-22/600666_20141223_2.pdf
635,2014-12-23,西南药业：控股股东及实际控制人关于股票交易异常波动的说明,/disclosure/listedinfo/announcement/c/2014-12-22/600666_20141223_3.pdf
636,2014-12-25,西南药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2014-12-24/600666_20141225_1.pdf
637,2014-12-27,西南药业关于召开2014年第四次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-12-26/600666_20141227_2.pdf
638,2014-12-27,西南药业关于公司收到政府补贴的公告,/disclosure/listedinfo/announcement/c/2014-12-26/600666_20141227_1.pdf
639,2014-12-27,西南药业2014年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-12-26/600666_20141227_3.pdf
640,2015-01-01,西南药业第七届监事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-31/600666_20150101_3.pdf
641,2015-01-01,西南药业第七届董事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-31/600666_20150101_2.pdf
642,2015-01-01,西南药业2014年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-12-31/600666_20150101_1.pdf
643,2015-01-01,西南药业2014年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-12-31/600666_20150101_4.pdf
644,2015-01-09,西南药业关于全资子公司完成工商注册登记的公告,/disclosure/listedinfo/announcement/c/2015-01-08/600666_20150109_1.pdf
645,2015-01-23,西南药业关于重大资产重组获得中华人民共和国工业和信息化部批复的公告,/disclosure/listedinfo/announcement/c/2015-01-22/600666_20150123_1.pdf
646,2015-01-27,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书摘要（草案修订稿）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_1.pdf
647,2015-01-27,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书（草案修订稿）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_8.pdf
648,2015-01-27,西南药业收购报告书（摘要）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_2.pdf
649,2015-01-27,西南药业简式权益变动报告书（上海泓成、上海祥禾及其一致行动人）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_3.pdf
650,2015-01-27,西南药业简式权益变动报告书（哈尔滨工业大学实业开发总公司）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_5.pdf
651,2015-01-27,西南药业简式权益变动报告（江苏高投成长价值股权投资合伙企业（有限合伙））,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_4.pdf
652,2015-01-27,西南药业独立董事关于公司对重大资产置换及发行股份购买资产并募集配套资金方案进行调整的独立意见,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_14.pdf
653,2015-01-27,西南药业第七届监事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_7.pdf
654,2015-01-27,西南药业第七届董事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_6.pdf
655,2015-01-27,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之独立财务顾问报告（修订稿）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_9.pdf
656,2015-01-27,西南药业：哈尔滨奥瑞德光电技术股份有限公司审计报告及财务报表（2012年1月1日至2014年12月31日止）,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_13.pdf
657,2015-01-27,西南药业：哈尔滨奥瑞德光电技术股份有限公司拟借壳西南药业股份有限公司实现上市项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_16.pdf
658,2015-01-27,西南药业：哈尔滨奥瑞德光电技术股份有限公司2015年盈利预测审核报告,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_15.pdf
659,2015-01-27,西南药业：北京国枫凯文律师事务所关于西南药业股份有限公司重大资产置换及发行股分购买资产并募集配套资金暨关联交易的补充法律意见书之二,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_11.pdf
660,2015-01-27,西南药业2015年备考合并盈利预测审核报告,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_12.pdf
661,2015-01-27,西南药业2014年1-9月审计报告,/disclosure/listedinfo/announcement/c/2015-01-26/600666_20150127_10.pdf
662,2015-01-28,西南药业关于提交公司发行股份购买资产申请材料反馈意见书面回复的公告,/disclosure/listedinfo/announcement/c/2015-01-27/600666_20150128_1.pdf
663,2015-02-10,西南药业关于收到中国证监会行政许可项目审查二次反馈意见通知书的公告,/disclosure/listedinfo/announcement/c/2015-02-09/600666_20150210_1.pdf
664,2015-03-10,西南药业关于中国证监会行政许可项目审查二次反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2015-03-09/600666_20150310_1.pdf
665,2015-03-12,西南药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_2.pdf
666,2015-03-12,西南药业年报摘要,/disclosure/listedinfo/announcement/c/2015-03-11/600666_2014_nzy.pdf
667,2015-03-12,西南药业年报,/disclosure/listedinfo/announcement/c/2015-03-11/600666_2014_n.pdf
668,2015-03-12,西南药业关于职工代表监事换届选举的公告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_3.pdf
669,2015-03-12,西南药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_7.pdf
670,2015-03-12,西南药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_12.pdf
671,2015-03-12,西南药业对外担保事项公告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_1.pdf
672,2015-03-12,西南药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_8.pdf
673,2015-03-12,西南药业独立董事关于对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_10.pdf
674,2015-03-12,西南药业独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_13.pdf
675,2015-03-12,西南药业第七届监事会第三十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_6.pdf
676,2015-03-12,西南药业第七届董事会审计委员会2014年履职情况报告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_16.pdf
677,2015-03-12,西南药业第七届董事会第三十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_5.pdf
678,2015-03-12,西南药业2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_11.pdf
679,2015-03-12,西南药业2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_15.pdf
680,2015-03-12,西南药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-03-11/600666_20150312_14.pdf
681,2015-03-13,西南药业关于追认2014年日常关联交易的公告,/disclosure/listedinfo/announcement/c/2015-03-12/600666_20150313_3.pdf
682,2015-03-13,西南药业关于召开2014年度网上业绩说明会的公告,/disclosure/listedinfo/announcement/c/2015-03-12/600666_20150313_1.pdf
683,2015-03-13,西南药业独立董事关于追认2014年度日常关联交易超额部分的独立意见,/disclosure/listedinfo/announcement/c/2015-03-12/600666_20150313_4.pdf
684,2015-03-13,西南药业第七届董事会第三十二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-12/600666_20150313_2.pdf
685,2015-03-14,西南药业日常关联交易的补充公告,/disclosure/listedinfo/announcement/c/2015-03-13/600666_20150314_3.pdf
686,2015-03-14,西南药业关于追认2014年日常关联交易的更正公告,/disclosure/listedinfo/announcement/c/2015-03-13/600666_20150314_2.pdf
687,2015-03-14,西南药业关于中国证监会上市公司并购重组审核委员会审核公司重大资产重组事项的停牌公告,/disclosure/listedinfo/announcement/c/2015-03-13/600666_20150314_1.pdf
688,2015-03-14,西南药业独立董事关于追认2014年度日常关联交易超额部分的独立意见,/disclosure/listedinfo/announcement/c/2015-03-13/600666_20150314_4.pdf
689,2015-03-14,西南药业独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-03-13/600666_20150314_5.pdf
690,2015-03-18,西南药业关于2014年度网上业绩说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2015-03-17/600666_20150318_1.pdf
691,2015-03-18,西南药业2014年度网上业绩说明会会议纪要,/disclosure/listedinfo/announcement/c/2015-03-17/600666_20150318_2.pdf
692,2015-03-20,西南药业关于公司重大资产重组事项获得中国证监会并购重组委审核通过暨公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2015-03-19/600666_20150320_1.pdf
693,2015-03-28,西南药业关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-03-27/600666_20150328_1.pdf
694,2015-03-28,西南药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-03-27/600666_20150328_3.pdf
695,2015-03-28,西南药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2015-03-27/600666_20150328_2.pdf
696,2015-03-28,西南药业2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-27/600666_20150328_4.pdf
697,2015-04-03,西南药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-04-02/600666_20150403_1.pdf
698,2015-04-03,西南药业2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-04-02/600666_20150403_2.pdf
699,2015-04-15,西南药业2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-04-14/600666_20150415_1.pdf
700,2015-04-18,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书摘要（草案修订稿）,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_8.pdf
701,2015-04-18,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书（草案修订稿）,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_7.pdf
702,2015-04-18,西南药业收购报告书,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_15.pdf
703,2015-04-18,西南药业关于重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告书的修订说明,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_16.pdf
704,2015-04-18,西南药业关于公司重大资产重组及向左洪波等发行股份购买资产并募集配套资金获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_4.pdf
705,2015-04-18,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_5.pdf
706,2015-04-18,西南药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-17/600666_2015_1.pdf
707,2015-04-18,西南药业第八届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_2.pdf
708,2015-04-18,西南药业第八届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_1.pdf
709,2015-04-18,西南药业：江海证券有限公司关于左洪波和褚淑霞及其一致行动人收购西南药业股份有限公司之财务顾问报告,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_13.pdf
710,2015-04-18,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之独立财务顾问报告（修订稿）,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_12.pdf
711,2015-04-18,西南药业：北京市金杜律师事务所关于《西南药业股份有限公司收购报告书》之法律意见书,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_14.pdf
712,2015-04-18,西南药业：北京国枫律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易的补充法律意见书之三,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_9.pdf
713,2015-04-18,西南药业：北京国枫凯文律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易的补充法律意见书之一,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_10.pdf
714,2015-04-18,西南药业：北京国枫凯文律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易的补充法律意见书之二,/disclosure/listedinfo/announcement/c/2015-04-17/600666_20150418_11.pdf
715,2015-04-24,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-04-23/600666_20150424_1.pdf
716,2015-04-30,西南药业关于实施2014年度利润分配预案后调整重大资产重组及募集配套资金的发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2015-04-29/600666_20150430_1.pdf
717,2015-05-05,西南药业关于重大资产重组事项注入资产过户完成情况的公告,/disclosure/listedinfo/announcement/c/2015-05-04/600666_20150505_1.pdf
718,2015-05-05,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易资产过户情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-05-04/600666_20150505_2.pdf
719,2015-05-05,西南药业：北京国枫律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之资产交割情况的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-04/600666_20150505_3.pdf
720,2015-05-08,西南药业关于实施2014年度利润分配预案后调整重大资产重组及募集配套资金的发行价格和发行数量的更正公告,/disclosure/listedinfo/announcement/c/2015-05-07/600666_20150508_1.pdf
721,2015-05-12,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易实施情况暨新增股份上市公告书（摘要）,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_9.pdf
722,2015-05-12,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易实施情况暨新增股份上市公告书,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_8.pdf
723,2015-05-12,西南药业关于重大资产重组事项注入资产过户完成情况备查文件的更正公告,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_1.pdf
724,2015-05-12,西南药业关于非公开发行股票发行结果暨股本变动的公告,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_2.pdf
725,2015-05-12,西南药业：验资报告,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_5.pdf
726,2015-05-12,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易资产过户情况之独立财务顾问核查意见（更正版）,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_4.pdf
727,2015-05-12,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_7.pdf
728,2015-05-12,西南药业：北京国枫律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之资产交割情况的补充法律意见书之一,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_3.pdf
729,2015-05-12,西南药业：北京国枫律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之实施情况的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-11/600666_20150512_6.pdf
730,2015-05-19,西南药业关于公司股东股权质押的公告,/disclosure/listedinfo/announcement/c/2015-05-18/600666_20150519_1.pdf
731,2015-05-20,西南药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-05-19/600666_20150520_1.pdf
732,2015-05-20,西南药业：左洪波、褚淑霞关于西南药业股份有限公司股票异动的回函,/disclosure/listedinfo/announcement/c/2015-05-19/600666_20150520_2.pdf
733,2015-05-22,西南药业关于股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-05-21/600666_20150522_1.pdf
734,2015-05-26,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-05-25/600666_20150526_1.pdf
735,2015-06-03,西南药业关于股东股份解除质押的公告,/disclosure/listedinfo/announcement/c/2015-06-02/600666_20150603_1.pdf
736,2015-06-05,西南药业关于股东股权过户完成的公告,/disclosure/listedinfo/announcement/c/2015-06-04/600666_20150605_1.pdf
737,2015-06-06,西南药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-06-05/600666_20150606_5.pdf
738,2015-06-06,西南药业关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-06-05/600666_20150606_3.pdf
739,2015-06-06,西南药业关于签订募集资金三方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-06-05/600666_20150606_4.pdf
740,2015-06-06,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-06-05/600666_20150606_6.pdf
741,2015-06-06,西南药业第八届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-05/600666_20150606_1.pdf
742,2015-06-06,西南药业第八届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-05/600666_20150606_2.pdf
743,2015-06-12,西南药业重大资产置换及发行股份购买资产并募集配套资金暨关联交易之非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2015-06-11/600666_20150612_5.pdf
744,2015-06-12,西南药业验资报告,/disclosure/listedinfo/announcement/c/2015-06-11/600666_20150612_3.pdf
745,2015-06-12,西南药业关于股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-06-11/600666_20150612_1.pdf
746,2015-06-12,西南药业非公开发行股票发行结构暨股本变动公告,/disclosure/listedinfo/announcement/c/2015-06-11/600666_20150612_2.pdf
747,2015-06-12,西南药业：海通证券股份有限公司关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之非公开发行股票发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2015-06-11/600666_20150612_6.pdf
748,2015-06-12,西南药业：北京国枫律师事务所关于西南药业股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之非公开发行股票发行过程及认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-11/600666_20150612_4.pdf
749,2015-06-13,西南药业关于使用募集资金对募投项目公司增资的公告,/disclosure/listedinfo/announcement/c/2015-06-12/600666_20150613_1.pdf
750,2015-06-13,西南药业关于签订募集资金四方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-06-12/600666_20150613_2.pdf
751,2015-06-13,西南药业第八届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-12/600666_20150613_4.pdf
752,2015-06-13,西南药业第八届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-12/600666_20150613_3.pdf
753,2015-06-17,西南药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2015-06-16/600666_20150617_2.pdf
754,2015-06-17,西南药业关于2015年第一次临时股东大会增加临时提案暨延期召开的公告,/disclosure/listedinfo/announcement/c/2015-06-16/600666_20150617_3.pdf
755,2015-06-17,西南药业第八届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-16/600666_20150617_1.pdf
756,2015-06-19,西南药业关于股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-06-18/600666_20150619_1.pdf
757,2015-06-20,西南药业2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-19/600666_20150620_1.pdf
758,2015-06-27,西南药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-06-26/600666_20150627_3.pdf
759,2015-06-27,西南药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-26/600666_20150627_1.pdf
760,2015-06-27,西南药业2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-26/600666_20150627_2.pdf
761,2015-07-02,西南药业以自筹资金预先投入募集资金投资项目的鉴证报告,/disclosure/listedinfo/announcement/c/2015-07-01/600666_20150702_5.pdf
762,2015-07-02,西南药业关于以募集资金置换预先投入募投项目自筹资金的公告,/disclosure/listedinfo/announcement/c/2015-07-01/600666_20150702_2.pdf
763,2015-07-02,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-07-01/600666_20150702_6.pdf
764,2015-07-02,西南药业第八届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-01/600666_20150702_1.pdf
765,2015-07-02,西南药业第八届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-01/600666_20150702_3.pdf
766,2015-07-02,西南药业：海通证券股份有限公司关于西南药业股份有限公司以募集资金置换预先已投入募集资金投资项目的自筹资金事项的核查意见,/disclosure/listedinfo/announcement/c/2015-07-01/600666_20150702_4.pdf
767,2015-07-03,西南药业关于变更公司名称的公告,/disclosure/listedinfo/announcement/c/2015-07-02/600666_20150703_1.pdf
768,2015-07-07,西南药业关于职工监事辞职及补选职工监事的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_7.pdf
769,2015-07-07,西南药业关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_10.pdf
770,2015-07-07,西南药业关于孙公司哈尔滨秋冠光电科技有限公司完成增资工商变更登记的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_1.pdf
771,2015-07-07,西南药业关于公司实际控制人及其一致行动人增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_11.pdf
772,2015-07-07,西南药业关于董事会秘书、证券事务代表辞职及聘任新董事会秘书、证券事务代表的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_4.pdf
773,2015-07-07,西南药业关于董事长辞职的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_2.pdf
774,2015-07-07,西南药业关于董事、监事及高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_3.pdf
775,2015-07-07,西南药业关于变更公司联系地址和联系方式的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_9.pdf
776,2015-07-07,西南药业关于变更2015年度财务审计和内部控制审计机构的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_8.pdf
777,2015-07-07,西南药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_13.pdf
778,2015-07-07,西南药业独立董事提名人声明（张鼎映、吉泽升）,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_12.pdf
779,2015-07-07,西南药业独立董事提名人声明（张波）,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_14.pdf
780,2015-07-07,西南药业独立董事候选人声明（张波）,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_16.pdf
781,2015-07-07,西南药业独立董事候选人声明（吉泽升、张鼎映）,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_15.pdf
782,2015-07-07,西南药业第八届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_6.pdf
783,2015-07-07,西南药业第八届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-06/600666_20150707_5.pdf
784,2015-07-08,西南药业关于筹划员工持股计划停牌的公告,/disclosure/listedinfo/announcement/c/2015-07-07/600666_20150708_1.pdf
785,2015-07-08,西南药业股票交易异动公告,/disclosure/listedinfo/announcement/c/2015-07-07/600666_20150708_2.pdf
786,2015-07-10,西南药业关于子公司哈尔滨奥瑞德光电技术有限公司完成增资工商变更登记的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600666_20150710_1.pdf
787,2015-07-13,西南药业关于股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2015-07-12/600666_20150713_1.pdf
788,2015-07-14,西南药业职工代表大会关于员工持股计划（草案）的决定,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_10.pdf
789,2015-07-14,西南药业员工持股计划（草案）摘要,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_3.pdf
790,2015-07-14,西南药业员工持股计划（草案）,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_8.pdf
791,2015-07-14,西南药业关于维护资本市场稳定的声明,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_7.pdf
792,2015-07-14,西南药业关于公司法定代表人变更的公告,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_6.pdf
793,2015-07-14,西南药业关于变更公司证券简称的公告,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_1.pdf
794,2015-07-14,西南药业关于2015年第二次临时股东大会增加临时提案暨延期召开的公告,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_4.pdf
795,2015-07-14,西南药业独立董事关于公司员工持股计划（草案）的独立意见,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_9.pdf
796,2015-07-14,西南药业第八届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_5.pdf
797,2015-07-14,西南药业第八届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-13/600666_20150714_2.pdf
798,2015-07-20,奥瑞德2015年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-07-20/600666_20150720_1.pdf
799,2015-07-25,奥瑞德关于子公司签订直接交易及输配电服务合同的公告,/disclosure/listedinfo/announcement/c/2015-07-24/600666_20150725_1.pdf
800,2015-07-25,奥瑞德：北京市金杜律师事务所关于奥瑞德光电股份有限公司实施员工持股计划的法律意见书,/disclosure/listedinfo/announcement/c/2015-07-24/600666_20150725_2.pdf
801,2015-07-28,奥瑞德总经理工作条例,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_29.pdf
802,2015-07-28,奥瑞德重大信息内部报告制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_28.pdf
803,2015-07-28,奥瑞德信息披露管理制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_31.pdf
804,2015-07-28,奥瑞德外部信息报送和使用人管理制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_27.pdf
805,2015-07-28,奥瑞德突发事件处理管理制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_26.pdf
806,2015-07-28,奥瑞德投资者关系管理制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_25.pdf
807,2015-07-28,奥瑞德年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_23.pdf
808,2015-07-28,奥瑞德内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_22.pdf
809,2015-07-28,奥瑞德内部控制制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_21.pdf
810,2015-07-28,奥瑞德关于子公司、孙公司使用闲置募集资金拟购买理财产品的公告,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_3.pdf
811,2015-07-28,奥瑞德关于召开2015年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_4.pdf
812,2015-07-28,奥瑞德关于孙公司哈尔滨秋冠光电科技有限公司吸收合并孙公司哈尔滨奥瑞德蓝宝石制品有限公司的公告,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_1.pdf
813,2015-07-28,奥瑞德关于设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_2.pdf
814,2015-07-28,奥瑞德关联交易管理办法,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_32.pdf
815,2015-07-28,奥瑞德公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_10.pdf
816,2015-07-28,奥瑞德对外投资管理办法,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_20.pdf
817,2015-07-28,奥瑞德独立董事制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_19.pdf
818,2015-07-28,奥瑞德独立董事意见,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_8.pdf
819,2015-07-28,奥瑞德独立董事意见,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_12.pdf
820,2015-07-28,奥瑞德独立董事审阅年报工作制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_18.pdf
821,2015-07-28,奥瑞德董事会战略委员会工作细则,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_17.pdf
822,2015-07-28,奥瑞德董事会薪酬与考核委员会工作细则,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_16.pdf
823,2015-07-28,奥瑞德董事会提名委员会工作细则,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_15.pdf
824,2015-07-28,奥瑞德董事会提案管理制度,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_14.pdf
825,2015-07-28,奥瑞德董事会审计委员会年报工作规程,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_30.pdf
826,2015-07-28,奥瑞德董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_24.pdf
827,2015-07-28,奥瑞德董事会秘书工作细则,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_13.pdf
828,2015-07-28,奥瑞德第八届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_7.pdf
829,2015-07-28,奥瑞德第八届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_6.pdf
830,2015-07-28,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司子公司、孙公司使用闲置募集资金购买理财产品的核查意见,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_9.pdf
831,2015-07-28,奥瑞德2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_5.pdf
832,2015-07-28,奥瑞德2015年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-07-27/600666_20150728_11.pdf
833,2015-07-30,奥瑞德关于重大资产重组实施完毕的公告,/disclosure/listedinfo/announcement/c/2015-07-29/600666_20150730_1.pdf
834,2015-07-30,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-07-29/600666_20150730_2.pdf
835,2015-07-30,奥瑞德：北京国枫律师事务所关于奥瑞德光电股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易之实施情况的补充法律意见书,/disclosure/listedinfo/announcement/c/2015-07-29/600666_20150730_3.pdf
836,2015-07-31,奥瑞德重大资产重组实施情况报告书,/disclosure/listedinfo/announcement/c/2015-07-30/600666_20150731_1.pdf
837,2015-08-01,奥瑞德关于子公司、孙公司使用闲置募集资金购买理财产品实施的公告,/disclosure/listedinfo/announcement/c/2015-08-01/600666_20150801_1.pdf
838,2015-08-07,奥瑞德关于子公司、孙公司使用闲置募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2015-08-07/600666_20150807_2.pdf
839,2015-08-07,奥瑞德2015年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-08-07/600666_20150807_1.pdf
840,2015-08-14,奥瑞德关于子公司、孙公司使用闲置募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2015-08-14/600666_20150814_1.pdf
841,2015-08-14,奥瑞德2015年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-08-14/600666_20150814_2.pdf
842,2015-08-14,奥瑞德2015年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-08-14/600666_20150814_3.pdf
843,2015-08-21,奥瑞德关于子公司、孙公司使用闲置募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2015-08-21/600666_20150821_1.pdf
844,2015-08-25,奥瑞德关于筹划非公开发行股票停牌的公告,/disclosure/listedinfo/announcement/c/2015-08-25/600666_20150825_1.pdf
845,2015-08-26,奥瑞德第八届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-26/600666_20150826_3.pdf
846,2015-08-26,奥瑞德第八届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-26/600666_20150826_2.pdf
847,2015-08-26,奥瑞德半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-26/600666_2015_zzy.pdf
848,2015-08-26,奥瑞德半年报,/disclosure/listedinfo/announcement/c/2015-08-26/600666_2015_z.pdf
849,2015-08-26,奥瑞德2015年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-08-26/600666_20150826_4.pdf
850,2015-08-29,奥瑞德关于筹划非公开发行股票进展情况的公告,/disclosure/listedinfo/announcement/c/2015-08-29/600666_20150829_1.pdf
851,2015-09-08,奥瑞德关于孙公司使用闲置募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2015-09-08/600666_20150908_1.pdf
852,2015-09-09,奥瑞德关于筹划非公开发行股票进展暨延期复牌的公告,/disclosure/listedinfo/announcement/c/2015-09-09/600666_20150909_1.pdf
853,2015-09-16,奥瑞德关于召开2015年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-09-16/600666_20150916_3.pdf
854,2015-09-16,奥瑞德关于公司筹划非公开发行股票进展暨第二次延期复牌的公告,/disclosure/listedinfo/announcement/c/2015-09-16/600666_20150916_2.pdf
855,2015-09-16,奥瑞德第八届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2015-09-16/600666_20150916_1.pdf
856,2015-09-17,奥瑞德关于2015年第四次临时股东大会通知的更正公告,/disclosure/listedinfo/announcement/c/2015-09-17/600666_20150917_1.pdf
857,2015-09-18,奥瑞德关于临时股东大会补充说明的公告,/disclosure/listedinfo/announcement/c/2015-09-18/600666_20150918_1.pdf
858,2015-09-23,奥瑞德关于筹划非公开发行股票事项进展情况的公告,/disclosure/listedinfo/announcement/c/2015-09-23/600666_20150923_1.pdf
859,2015-09-30,奥瑞德关于筹划非公开发行股票事项进展情况的公告,/disclosure/listedinfo/announcement/c/2015-09-30/600666_20150930_1.pdf
860,2015-09-30,奥瑞德2015年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-09-30/600666_20150930_2.pdf
861,2015-10-09,奥瑞德关于设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2015-10-09/600666_20151009_3.pdf
862,2015-10-09,奥瑞德关于公司筹划非公开发行股票进展暨第三次延期复牌的公告,/disclosure/listedinfo/announcement/c/2015-10-09/600666_20151009_2.pdf
863,2015-10-09,奥瑞德2015年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-10-09/600666_20151009_1.pdf
864,2015-10-09,奥瑞德2015年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-10-09/600666_20151009_4.pdf
865,2015-10-16,奥瑞德关于筹划非公开发行股票事项进展情况的公告,/disclosure/listedinfo/announcement/c/2015-10-16/600666_20151016_1.pdf
866,2015-10-22,奥瑞德关于股东进行股票质押式回购交易的公告,/disclosure/listedinfo/announcement/c/2015-10-22/600666_20151022_1.pdf
867,2015-10-24,奥瑞德关于全资子公司取得营业执照的公告,/disclosure/listedinfo/announcement/c/2015-10-24/600666_20151024_2.pdf
868,2015-10-24,奥瑞德关于筹划非公开发行股票事项进展情况的公告,/disclosure/listedinfo/announcement/c/2015-10-24/600666_20151024_1.pdf
869,2015-10-29,奥瑞德第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-29/600666_2015_3.pdf
870,2015-10-31,奥瑞德关于筹划非公开发行股票事项进展情况的公告,/disclosure/listedinfo/announcement/c/2015-10-31/600666_20151031_1.pdf
871,2015-11-06,奥瑞德关于终止筹划非公开发行股票事项召开投资者说明会的预告公告,/disclosure/listedinfo/announcement/c/2015-11-06/600666_20151106_1.pdf
872,2015-11-06,奥瑞德关于终止筹划非公开发行股票事项并筹划重大资产重组事项停牌的公告,/disclosure/listedinfo/announcement/c/2015-11-06/600666_20151106_2.pdf
873,2015-11-11,奥瑞德关于投资者说明会召开情况及相关内容的公告,/disclosure/listedinfo/announcement/c/2015-11-11/600666_20151111_1.pdf
874,2015-11-13,奥瑞德关于筹划重大资产重组进展情况的公告,/disclosure/listedinfo/announcement/c/2015-11-13/600666_20151113_1.pdf
875,2015-11-20,奥瑞德重大资产购买报告书摘要,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_4.pdf
876,2015-11-20,奥瑞德重大资产购买报告书,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_7.pdf
877,2015-11-20,奥瑞德关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_5.pdf
878,2015-11-20,奥瑞德关于召开2015年第五次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_3.pdf
879,2015-11-20,奥瑞德关于对控股孙公司增资的公告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_6.pdf
880,2015-11-20,奥瑞德独立董事关于公司重大资产购买事项的事前认可意见,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_14.pdf
881,2015-11-20,奥瑞德独立董事关于公司重大资产购买事项的独立意见,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_11.pdf
882,2015-11-20,奥瑞德第八届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_2.pdf
883,2015-11-20,奥瑞德第八届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_1.pdf
884,2015-11-20,奥瑞德备考财务报表的审阅报告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_12.pdf
885,2015-11-20,奥瑞德：新时代证券股份有限公司关于奥瑞德光电股份有限公司重大资产购买之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_13.pdf
886,2015-11-20,奥瑞德：江西新航科技有限公司审计报告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_8.pdf
887,2015-11-20,奥瑞德：哈尔滨奥瑞德光电技术有限公司拟现金收购江西新航科技有限公司股权项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_9.pdf
888,2015-11-20,奥瑞德：北京国枫律师事务所关于奥瑞德光电股份有限公司重大资产购买的法律意见书,/disclosure/listedinfo/announcement/c/2015-11-20/600666_20151120_10.pdf
889,2015-11-26,奥瑞德关于全资子公司拟申请银行贷款暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2015-11-26/600666_20151126_1.pdf
890,2015-11-26,奥瑞德关于2015年第五次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2015-11-26/600666_20151126_2.pdf
891,2015-11-26,奥瑞德独立董事关于关联担保的独立意见,/disclosure/listedinfo/announcement/c/2015-11-26/600666_20151126_3.pdf
892,2015-12-02,奥瑞德关于收到《关于奥瑞德光电股份有限公司重大资产购买报告书的事后审核意见函》的公告,/disclosure/listedinfo/announcement/c/2015-12-02/600666_20151202_1.pdf
893,2015-12-02,奥瑞德2015年第五次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-12-02/600666_20151202_2.pdf
894,2015-12-04,奥瑞德重大资产购买报告书摘要（修订版）,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_9.pdf
895,2015-12-04,奥瑞德重大资产购买报告书（修订稿）,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_8.pdf
896,2015-12-04,奥瑞德关于重大资产购买报告书审核意见函的反馈回复,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_4.pdf
897,2015-12-04,奥瑞德关于媒体报导的澄清公告,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_3.pdf
898,2015-12-04,奥瑞德关于公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_2.pdf
899,2015-12-04,奥瑞德关于《上海证券交易所对公司重大资产购买报告书的事后审核意见函》的回复公告,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_1.pdf
900,2015-12-04,奥瑞德：新时代证券股份有限公司关于上海证券交易所《关于对奥瑞德光电股份有限公司重大资产购买报告书的事后审核意见函》中相关事项之核查意见,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_7.pdf
901,2015-12-04,奥瑞德：关于奥瑞德光电股份有限公司重大资产购买报告书的事后审核意见函回复,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_6.pdf
902,2015-12-04,奥瑞德：北京国枫律师事务所关于奥瑞德光电股份有限公司重大资产购买的补充法律意见书之一,/disclosure/listedinfo/announcement/c/2015-12-04/600666_20151204_5.pdf
903,2015-12-08,奥瑞德股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-12-08/600666_20151208_2.pdf
904,2015-12-08,奥瑞德：左洪波、褚淑霞关于奥瑞德光电股份有限公司股票异动的回函,/disclosure/listedinfo/announcement/c/2015-12-08/600666_20151208_4.pdf
905,2015-12-08,奥瑞德2015年第五次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-12-08/600666_20151208_1.pdf
906,2015-12-08,奥瑞德2015年第五次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-08/600666_20151208_3.pdf
907,2015-12-09,奥瑞德股票交易异常波动的补充公告,/disclosure/listedinfo/announcement/c/2015-12-09/600666_20151209_1.pdf
908,2015-12-10,奥瑞德股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-12-10/600666_20151210_1.pdf
909,2015-12-10,奥瑞德：控股股东及实际控制人书面回函,/disclosure/listedinfo/announcement/c/2015-12-10/600666_20151210_2.pdf
910,2015-12-12,奥瑞德重大资产购买实施情况报告书,/disclosure/listedinfo/announcement/c/2015-12-12/600666_20151212_1.pdf
911,2015-12-12,奥瑞德关于重大资产收购完成工商变更的公告,/disclosure/listedinfo/announcement/c/2015-12-12/600666_20151212_2.pdf
912,2015-12-12,奥瑞德：新时代证券股份有限公司关于奥瑞德光电股份有限公司重大资产购买实施情况之核查意见,/disclosure/listedinfo/announcement/c/2015-12-12/600666_20151212_3.pdf
913,2015-12-12,奥瑞德：北京国枫律师事务所关于奥瑞德光电股份有限公司重大资产购买实施情况的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-12/600666_20151212_4.pdf
914,2015-12-15,奥瑞德关于全资子公司签署贷款合同暨实际控制人及公司签署担保合同的公告,/disclosure/listedinfo/announcement/c/2015-12-15/600666_20151215_1.pdf
915,2016-01-05,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司持续督导2015年度之现场检查报告,/disclosure/listedinfo/announcement/c/2016-01-05/600666_20160105_1.pdf
916,2016-01-08,奥瑞德关于使用部分募集资金以及自有资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2016-01-08/600666_20160108_1.pdf
917,2016-01-12,奥瑞德关于员工持股计划完成股票购买的公告,/disclosure/listedinfo/announcement/c/2016-01-12/600666_20160112_1.pdf
918,2016-01-20,奥瑞德关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-01-20/600666_20160120_3.pdf
919,2016-01-20,奥瑞德关于对外投资参与设立内蒙古金奥光电科技有限公司的公告,/disclosure/listedinfo/announcement/c/2016-01-20/600666_20160120_2.pdf
920,2016-01-20,奥瑞德关于对外投资参与设立湖北宝塔光电科技有限公司的公告,/disclosure/listedinfo/announcement/c/2016-01-20/600666_20160120_1.pdf
921,2016-01-23,奥瑞德2015年度业绩预增公告,/disclosure/listedinfo/announcement/c/2016-01-23/600666_20160123_1.pdf
922,2016-01-26,奥瑞德关于合作设立有限责任公司取得营业执照的公告,/disclosure/listedinfo/announcement/c/2016-01-26/600666_20160126_1.pdf
923,2016-01-28,奥瑞德关于全资子公司收到政府奖励补助的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-28/600666_20160128_1.pdf
924,2016-02-02,奥瑞德2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-02-02/600666_20160202_1.pdf
925,2016-02-05,奥瑞德2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-02-05/600666_20160205_1.pdf
926,2016-02-05,奥瑞德2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-02-05/600666_20160205_2.pdf
927,2016-02-16,奥瑞德关于孙公司使用部分募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2016-02-16/600666_20160216_1.pdf
928,2016-03-11,奥瑞德审计报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_15.pdf
929,2016-03-11,奥瑞德年报摘要,/disclosure/listedinfo/announcement/c/2016-03-11/600666_2015_nzy.pdf
930,2016-03-11,奥瑞德年报,/disclosure/listedinfo/announcement/c/2016-03-11/600666_2015_n.pdf
931,2016-03-11,奥瑞德内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_21.pdf
932,2016-03-11,奥瑞德募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_19.pdf
933,2016-03-11,奥瑞德控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_16.pdf
934,2016-03-11,奥瑞德关于召开2015年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_8.pdf
935,2016-03-11,奥瑞德关于投资设立产业并购基金暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_7.pdf
936,2016-03-11,奥瑞德关于全资子公司拟申请银行贷款暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_6.pdf
937,2016-03-11,奥瑞德关于计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_3.pdf
938,2016-03-11,奥瑞德关于公司2015年度日常关联交易执行情况及2016年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_5.pdf
939,2016-03-11,奥瑞德独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_13.pdf
940,2016-03-11,奥瑞德独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_12.pdf
941,2016-03-11,奥瑞德独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_17.pdf
942,2016-03-11,奥瑞德董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_23.pdf
943,2016-03-11,奥瑞德第八届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_2.pdf
944,2016-03-11,奥瑞德第八届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_1.pdf
945,2016-03-11,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易事项之2015年度持续督导意见,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_24.pdf
946,2016-03-11,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司盈利预测实现情况的专项核查意见,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_25.pdf
947,2016-03-11,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司2015年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_22.pdf
948,2016-03-11,奥瑞德：哈尔滨奥瑞德光电技术有限公司重大资产重组业绩承诺实现情况说明的审核报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_20.pdf
949,2016-03-11,奥瑞德2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_18.pdf
950,2016-03-11,奥瑞德2015年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_4.pdf
951,2016-03-11,奥瑞德2015年度监事会工作报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_11.pdf
952,2016-03-11,奥瑞德2015年度董事会工作报告,/disclosure/listedinfo/announcement/c/2016-03-11/600666_20160311_10.pdf
953,2016-03-12,奥瑞德关于完成孙公司间吸收合并的公告,/disclosure/listedinfo/announcement/c/2016-03-12/600666_20160312_2.pdf
954,2016-03-12,奥瑞德：哈尔滨奥瑞德光电技术有限公司盈利预测与实际经营差异表的审核报告,/disclosure/listedinfo/announcement/c/2016-03-12/600666_20160312_1.pdf
955,2016-03-18,奥瑞德关于召开2015年度利润分配网上投资者说明会的预告公告,/disclosure/listedinfo/announcement/c/2016-03-18/600666_20160318_1.pdf
956,2016-03-22,奥瑞德关于2015年度利润分配网上投资者说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2016-03-22/600666_20160322_1.pdf
957,2016-03-24,奥瑞德：新时代证券股份有限公司关于奥瑞德光电股份有限公司重大资产购买之持续督导工作报告（2015年度）,/disclosure/listedinfo/announcement/c/2016-03-24/600666_20160324_1.pdf
958,2016-03-24,奥瑞德2015年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-03-24/600666_20160324_2.pdf
959,2016-03-29,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2016-03-29/600666_20160329_1.pdf
960,2016-04-01,奥瑞德2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-01/600666_20160401_2.pdf
961,2016-04-01,奥瑞德2015年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-01/600666_20160401_1.pdf
962,2016-04-07,奥瑞德关于孙公司使用部分募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2016-04-07/600666_20160407_1.pdf
963,2016-04-07,奥瑞德关于全资子公司签署贷款合同暨公司及实际控制人签署担保合同的公告,/disclosure/listedinfo/announcement/c/2016-04-07/600666_20160407_3.pdf
964,2016-04-07,奥瑞德关于控股股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2016-04-07/600666_20160407_2.pdf
965,2016-04-07,奥瑞德关于合作投资设立合伙企业暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-07/600666_20160407_4.pdf
966,2016-04-07,奥瑞德独立董事意见,/disclosure/listedinfo/announcement/c/2016-04-07/600666_20160407_5.pdf
967,2016-04-12,奥瑞德关于合作投资设立合伙企业取得营业执照的公告,/disclosure/listedinfo/announcement/c/2016-04-12/600666_20160412_1.pdf
968,2016-04-19,奥瑞德关于终止合作投资设立内蒙古金奥光电科技有限公司的公告,/disclosure/listedinfo/announcement/c/2016-04-19/600666_20160419_1.pdf
969,2016-04-26,奥瑞德关于投资设立产业并购基金取得营业执照的公告,/disclosure/listedinfo/announcement/c/2016-04-26/600666_20160426_2.pdf
970,2016-04-26,奥瑞德关于全资子公司收到政府奖励资金的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-26/600666_20160426_1.pdf
971,2016-04-28,奥瑞德2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600666_2016_1.pdf
972,2016-05-07,奥瑞德关于全资孙公司对外投资的公告,/disclosure/listedinfo/announcement/c/2016-05-07/600666_20160507_1.pdf
973,2016-05-10,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2016-05-10/600666_20160510_1.pdf
974,2016-05-13,奥瑞德关于全资子公司收到政府奖励资金的提示性公告,/disclosure/listedinfo/announcement/c/2016-05-13/600666_20160513_1.pdf
975,2016-05-14,奥瑞德关于重大资产重组部分限售股上市流通的提示性公告,/disclosure/listedinfo/announcement/c/2016-05-14/600666_20160514_1.pdf
976,2016-05-14,奥瑞德关于持股5%以上股东减持股份计划的公告,/disclosure/listedinfo/announcement/c/2016-05-14/600666_20160514_2.pdf
977,2016-05-14,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司重大资产重组部分限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-05-14/600666_20160514_3.pdf
978,2016-05-19,奥瑞德关于股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2016-05-19/600666_20160519_1.pdf
979,2016-05-26,奥瑞德关于持股5%以上股东减持股份计划的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600666_20160526_1.pdf
980,2016-06-03,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2016-06-03/600666_20160603_1.pdf
981,2016-06-09,奥瑞德简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-06-09/600666_20160609_3.pdf
982,2016-06-09,奥瑞德关于重大资产重组之发行股份募集配套资金限售股上市流通的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-09/600666_20160609_1.pdf
983,2016-06-09,奥瑞德关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-09/600666_20160609_2.pdf
984,2016-06-09,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司重大资产重组之发行股份募集配套资金限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-06-09/600666_20160609_4.pdf
985,2016-06-14,奥瑞德关于全资子公司成功研发大尺寸蓝宝石晶体的公告,/disclosure/listedinfo/announcement/c/2016-06-14/600666_20160614_1.pdf
986,2016-06-15,奥瑞德关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2016-06-15/600666_20160615_2.pdf
987,2016-06-15,奥瑞德关于临时停牌的公告,/disclosure/listedinfo/announcement/c/2016-06-15/600666_20160615_1.pdf
988,2016-06-16,奥瑞德关于上海证券交易所问询函的回复暨股票复牌的公告,/disclosure/listedinfo/announcement/c/2016-06-16/600666_20160616_1.pdf
989,2016-06-17,奥瑞德关于股东股权解除质押的公告,/disclosure/listedinfo/announcement/c/2016-06-17/600666_20160617_1.pdf
990,2016-06-24,奥瑞德简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-06-24/600666_20160624_2.pdf
991,2016-06-24,奥瑞德关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-24/600666_20160624_1.pdf
992,2016-06-25,奥瑞德关于合作投资的通宝（湖北）产业投资壹号基金后续进展公告,/disclosure/listedinfo/announcement/c/2016-06-25/600666_20160625_1.pdf
993,2016-06-28,奥瑞德关于合作投资的通宝（湖北）产业投资壹号基金的补充公告,/disclosure/listedinfo/announcement/c/2016-06-28/600666_20160628_1.pdf
994,2016-06-29,奥瑞德简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-06-29/600666_20160629_2.pdf
995,2016-06-29,奥瑞德关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-29/600666_20160629_1.pdf
996,2016-07-07,奥瑞德简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-07-07/600666_20160707_2.pdf
997,2016-07-07,奥瑞德关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-07/600666_20160707_1.pdf
998,2016-07-13,奥瑞德关于孙公司使用部分募集资金购买理财产品的实施公告,/disclosure/listedinfo/announcement/c/2016-07-13/600666_20160713_1.pdf
999,2016-07-20,奥瑞德关于转让通宝（湖北）产业投资壹号基金（有限合伙）认缴出资份额暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_3.pdf
1000,2016-07-20,奥瑞德关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_6.pdf
1001,2016-07-20,奥瑞德关于投资设立控股孙公司的公告,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_4.pdf
1002,2016-07-20,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_7.pdf
1003,2016-07-20,奥瑞德关于公司及全资子公司拟申请银行授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_5.pdf
1004,2016-07-20,奥瑞德独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_8.pdf
1005,2016-07-20,奥瑞德董事会审计委员会关于相关事项的书面审核意见,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_9.pdf
1006,2016-07-20,奥瑞德第八届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_2.pdf
1007,2016-07-20,奥瑞德第八届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-20/600666_20160720_1.pdf
1008,2016-07-21,奥瑞德关于筹划重大事项的停牌公告,/disclosure/listedinfo/announcement/c/2016-07-21/600666_20160721_1.pdf
1009,2016-07-26,奥瑞德关于全资子公司签订重大合同的公告,/disclosure/listedinfo/announcement/c/2016-07-26/600666_20160726_2.pdf
1010,2016-07-26,奥瑞德关于公司全资子公司变更经营范围的公告,/disclosure/listedinfo/announcement/c/2016-07-26/600666_20160726_3.pdf
1011,2016-07-26,奥瑞德关于公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-26/600666_20160726_1.pdf
1012,2016-07-29,奥瑞德2016年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-07-29/600666_20160729_1.pdf
1013,2016-08-05,奥瑞德2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-08-05/600666_20160805_1.pdf
1014,2016-08-05,奥瑞德2016年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-08-05/600666_20160805_2.pdf
1015,2016-08-09,奥瑞德关于与华映科技（集团）股份有限公司签订框架合作协议的公告,/disclosure/listedinfo/announcement/c/2016-08-09/600666_20160809_1.pdf
1016,2016-08-13,奥瑞德关于筹划非公开发行股票停牌的公告,/disclosure/listedinfo/announcement/c/2016-08-13/600666_20160813_1.pdf
1017,2016-08-20,奥瑞德关于设立控股孙公司取得营业执照的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600666_20160820_2.pdf
1018,2016-08-20,奥瑞德关于筹划非公开发行股票事项进展情况的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600666_20160820_1.pdf
1019,2016-08-26,奥瑞德第八届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-26/600666_20160826_2.pdf
1020,2016-08-26,奥瑞德第八届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-26/600666_20160826_1.pdf
1021,2016-08-26,奥瑞德2016年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-26/600666_20160826_3.pdf
1022,2016-08-26,奥瑞德2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-26/600666_2016_zzy.pdf
1023,2016-08-26,奥瑞德2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-26/600666_2016_z.pdf
1024,2016-08-27,奥瑞德全体董事、高级管理人员关于公司非公开发行A股股票摊薄即期回报采取填补措施的承诺函,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_12.pdf
1025,2016-08-27,奥瑞德前次募集资金使用情况专项报告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_14.pdf
1026,2016-08-27,奥瑞德前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_15.pdf
1027,2016-08-27,奥瑞德控股股东、实际控制人关于公司非公开发行A股股票摊薄即期回报采取填补措施的承诺函,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_11.pdf
1028,2016-08-27,奥瑞德关于召开2016年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_6.pdf
1029,2016-08-27,奥瑞德关于完成营业执照、组织机构代码证、税务登记证“三证合一”的公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_8.pdf
1030,2016-08-27,奥瑞德关于全资子公司拟申请银行综合授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_3.pdf
1031,2016-08-27,奥瑞德关于公司未来三年（2016-2018年）股东分红回报规划的公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_5.pdf
1032,2016-08-27,奥瑞德关于公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_4.pdf
1033,2016-08-27,奥瑞德关于非公开发行A股股票摊薄即期回报对公司主要财务指标的影响及公司采取措施的说明公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_7.pdf
1034,2016-08-27,奥瑞德独立董事关于非公开发行等相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_10.pdf
1035,2016-08-27,奥瑞德第八届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_2.pdf
1036,2016-08-27,奥瑞德第八届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_1.pdf
1037,2016-08-27,奥瑞德2016年非公开发行股票预案,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_9.pdf
1038,2016-08-27,奥瑞德2016年非公开发行股票募集资金使用可行性分析报告,/disclosure/listedinfo/announcement/c/2016-08-27/600666_20160827_13.pdf
1039,2016-08-30,奥瑞德关于收到政府上市奖励资金的公告,/disclosure/listedinfo/announcement/c/2016-08-30/600666_20160830_1.pdf
1040,2016-09-01,奥瑞德关于通宝（湖北）产业投资壹号基金（有限合伙）认缴出资份额转让完成工商变更的公告,/disclosure/listedinfo/announcement/c/2016-09-01/600666_20160901_1.pdf
1041,2016-09-03,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司2016年半年度募集资金存放与实际使用情况的核查意见,/disclosure/listedinfo/announcement/c/2016-09-03/600666_20160903_1.pdf
1042,2016-09-06,奥瑞德2016年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-09-06/600666_20160906_1.pdf
1043,2016-09-07,奥瑞德关于变更投资者联系电话及传真号码的公告,/disclosure/listedinfo/announcement/c/2016-09-07/600666_20160907_1.pdf
1044,2016-09-13,奥瑞德关于公司控股股东及其一致行动人股权质押的公告,/disclosure/listedinfo/announcement/c/2016-09-13/600666_20160913_2.pdf
1045,2016-09-13,奥瑞德2016年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-13/600666_20160913_1.pdf
1046,2016-09-13,奥瑞德2016年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-13/600666_20160913_3.pdf
1047,2016-10-28,奥瑞德2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/600666_2016_3.pdf
1048,2016-11-15,奥瑞德关于召开2016年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_5.pdf
1049,2016-11-15,奥瑞德关于增加2016年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_3.pdf
1050,2016-11-15,奥瑞德关于全资子公司拟申请贷款或银行授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_4.pdf
1051,2016-11-15,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_6.pdf
1052,2016-11-15,奥瑞德董事会审计委员会关于相关事项的书面核查意见,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_7.pdf
1053,2016-11-15,奥瑞德第八届监事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_2.pdf
1054,2016-11-15,奥瑞德第八届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-15/600666_20161115_1.pdf
1055,2016-11-17,奥瑞德关于参加“2016年重庆辖区上市公司投资者网上接待日主题活动”的公告,/disclosure/listedinfo/announcement/c/2016-11-17/600666_20161117_1.pdf
1056,2016-11-18,奥瑞德关于收到《中国证监会行政许可申请受理通知书》的公告,/disclosure/listedinfo/announcement/c/2016-11-18/600666_20161118_1.pdf
1057,2016-11-24,奥瑞德关于子公司签署日常经营合同的公告,/disclosure/listedinfo/announcement/c/2016-11-24/600666_20161124_2.pdf
1058,2016-11-24,奥瑞德2016年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-11-24/600666_20161124_1.pdf
1059,2016-12-01,奥瑞德2016年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-12-01/600666_20161201_1.pdf
1060,2016-12-01,奥瑞德2016年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-12-01/600666_20161201_2.pdf
1061,2016-12-15,奥瑞德关于公司股东股权质押的公告,/disclosure/listedinfo/announcement/c/2016-12-15/600666_20161215_1.pdf
1062,2016-12-21,奥瑞德关于收到《中国证监会行政许可项目审查反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2016-12-21/600666_20161221_1.pdf
1063,2017-01-04,奥瑞德关于收到中国证监会重庆监管局责令改正措施决定的公告,/disclosure/listedinfo/announcement/c/2017-01-04/600666_20170104_1.pdf
1064,2017-01-04,奥瑞德关于董事暨高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2017-01-04/600666_20170104_2.pdf
1065,2017-01-05,奥瑞德关于筹划重大事项停牌的公告,/disclosure/listedinfo/announcement/c/2017-01-05/600666_20170105_1.pdf
1066,2017-01-07,奥瑞德全体董事、高级管理人员关于公司非公开发行A股股票摊薄即期回报采取填补措施的承诺函,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_13.pdf
1067,2017-01-07,奥瑞德控股股东、实际控制人关于公司非公开发行A股股票摊薄即期回报采取填补措施的承诺函,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_12.pdf
1068,2017-01-07,奥瑞德关于追认控股股东提供借款财务资助暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_6.pdf
1069,2017-01-07,奥瑞德关于追认及授权使用自有资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_5.pdf
1070,2017-01-07,奥瑞德关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_8.pdf
1071,2017-01-07,奥瑞德关于申请延期回复非公开发行股票反馈意见的公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_11.pdf
1072,2017-01-07,奥瑞德关于全资子公司拟申请银行授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_7.pdf
1073,2017-01-07,奥瑞德关于非公开发行A股股票摊薄即期回报对公司主要财务指标的影响及公司采取措施的说明（修订稿）公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_4.pdf
1074,2017-01-07,奥瑞德关于调整公司2016年非公开发行股票方案的公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_3.pdf
1075,2017-01-07,奥瑞德关于变更重大资产重组持续督导期之独立财务顾问主办人的公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_10.pdf
1076,2017-01-07,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_14.pdf
1077,2017-01-07,奥瑞德董事会审计委员会关于相关事项的书面核查意见,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_15.pdf
1078,2017-01-07,奥瑞德第八届监事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_2.pdf
1079,2017-01-07,奥瑞德第八届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_1.pdf
1080,2017-01-07,奥瑞德2016年非公开发行股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_9.pdf
1081,2017-01-07,奥瑞德2016年非公开发行股票募集资金使用可行性分析报告（修订稿）,/disclosure/listedinfo/announcement/c/2017-01-07/600666_20170107_16.pdf
1082,2017-01-11,奥瑞德关于终止筹划重大事项暨股票复牌的公告,/disclosure/listedinfo/announcement/c/2017-01-11/600666_20170111_1.pdf
1083,2017-01-13,奥瑞德关于实际控制人暨控股股东增持公司股份计划的公告,/disclosure/listedinfo/announcement/c/2017-01-13/600666_20170113_1.pdf
1084,2017-01-19,奥瑞德2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-01-19/600666_20170119_1.pdf
1085,2017-01-20,奥瑞德关于重庆证监局对公司采取责令改正措施决定的整改报告,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_4.pdf
1086,2017-01-20,奥瑞德关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_5.pdf
1087,2017-01-20,奥瑞德关于使用募集资金开具银行承兑汇票支付募投项目款项的确认及调整募投项目实施方式和部分募投项目延期的公告,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_3.pdf
1088,2017-01-20,奥瑞德关于变更重大资产购买项目持续督导之独立财务顾问主办人的公告,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_6.pdf
1089,2017-01-20,奥瑞德独立董事意见,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_9.pdf
1090,2017-01-20,奥瑞德第八届监事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_2.pdf
1091,2017-01-20,奥瑞德第八届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_1.pdf
1092,2017-01-20,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司前期使用募集资金开具银行承兑汇票支付募投项目款项的确认及调整募投项目具体实施方式和部分募投项目进度延期的核查意见,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_8.pdf
1093,2017-01-20,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司持续督导2016年度之现场检查报告,/disclosure/listedinfo/announcement/c/2017-01-20/600666_20170120_7.pdf
1094,2017-01-24,奥瑞德2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-01-24/600666_20170124_2.pdf
1095,2017-01-24,奥瑞德2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-01-24/600666_20170124_3.pdf
1096,2017-01-24,奥瑞德2017年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-01-24/600666_20170124_1.pdf
1097,2017-01-25,奥瑞德关于注销全资子公司的公告,/disclosure/listedinfo/announcement/c/2017-01-25/600666_20170125_2.pdf
1098,2017-01-25,奥瑞德2016年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-25/600666_20170125_1.pdf
1099,2017-01-26,奥瑞德关于公司股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-01-26/600666_20170126_1.pdf
1100,2017-02-07,奥瑞德2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-02-07/600666_20170207_1.pdf
1101,2017-02-07,奥瑞德2017年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-02-07/600666_20170207_2.pdf
1102,2017-02-11,奥瑞德关于最近五年被证券监管部门和交易所采取监管措施或处罚及整改情况的公告,/disclosure/listedinfo/announcement/c/2017-02-11/600666_20170211_2.pdf
1103,2017-02-11,奥瑞德关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2017-02-11/600666_20170211_1.pdf
1104,2017-02-11,奥瑞德关于不存在变相通过本次募集资金实施重大投资或资产购买的情形的承诺,/disclosure/listedinfo/announcement/c/2017-02-11/600666_20170211_5.pdf
1105,2017-02-11,奥瑞德非公开发行股票申请文件反馈意见的回复,/disclosure/listedinfo/announcement/c/2017-02-11/600666_20170211_4.pdf
1106,2017-02-11,奥瑞德：关于奥瑞德光电股份有限公司中国证监会行政许可项目审查反馈意见通知书之反馈意见答复,/disclosure/listedinfo/announcement/c/2017-02-11/600666_20170211_3.pdf
1107,2017-02-14,奥瑞德关于召开2017年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-02-14/600666_20170214_3.pdf
1108,2017-02-14,奥瑞德关于下属公司拟申请银行授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-02-14/600666_20170214_2.pdf
1109,2017-02-14,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-02-14/600666_20170214_4.pdf
1110,2017-02-14,奥瑞德第八届董事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-02-14/600666_20170214_1.pdf
1111,2017-02-23,奥瑞德关于控股股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2017-02-23/600666_20170223_2.pdf
1112,2017-02-23,奥瑞德2017年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-02-23/600666_20170223_1.pdf
1113,2017-03-02,奥瑞德关于控股股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2017-03-02/600666_20170302_1.pdf
1114,2017-03-02,奥瑞德2017年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-03-02/600666_20170302_2.pdf
1115,2017-03-02,奥瑞德2017年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-03-02/600666_20170302_3.pdf
1116,2017-03-08,奥瑞德关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_7.pdf
1117,2017-03-08,奥瑞德关于计提资产减值准备的公告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_6.pdf
1118,2017-03-08,奥瑞德关于公司2016年度日常关联交易执行情况及2017年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_4.pdf
1119,2017-03-08,奥瑞德关于董事会审议高送转预案的公告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_5.pdf
1120,2017-03-08,奥瑞德独立董事关于相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_11.pdf
1121,2017-03-08,奥瑞德独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_15.pdf
1122,2017-03-08,奥瑞德董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_20.pdf
1123,2017-03-08,奥瑞德第八届监事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_2.pdf
1124,2017-03-08,奥瑞德第八届董事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_1.pdf
1125,2017-03-08,奥瑞德：审计报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_13.pdf
1126,2017-03-08,奥瑞德：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_18.pdf
1127,2017-03-08,奥瑞德：募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_10.pdf
1128,2017-03-08,奥瑞德：募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_16.pdf
1129,2017-03-08,奥瑞德：控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_14.pdf
1130,2017-03-08,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司2016年度业绩承诺实现情况的专项核查意见,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_21.pdf
1131,2017-03-08,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司2016年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_19.pdf
1132,2017-03-08,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司2016年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_9.pdf
1133,2017-03-08,奥瑞德：哈尔滨奥瑞德光电技术有限公司重大资产重组业绩承诺实现情况说明的审核报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_17.pdf
1134,2017-03-08,奥瑞德2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-08/600666_2016_nzy.pdf
1135,2017-03-08,奥瑞德2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_2016_n.pdf
1136,2017-03-08,奥瑞德2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_22.pdf
1137,2017-03-08,奥瑞德2016年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-03-08/600666_20170308_3.pdf
1138,2017-03-09,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-03-09/600666_20170309_1.pdf
1139,2017-03-14,奥瑞德关于公司股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-03-14/600666_20170314_1.pdf
1140,2017-03-17,奥瑞德关于全资子公司拟为其下属全资孙公司提供担保的公告,/disclosure/listedinfo/announcement/c/2017-03-17/600666_20170317_2.pdf
1141,2017-03-17,奥瑞德关于公司股东为控股孙公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-03-17/600666_20170317_3.pdf
1142,2017-03-17,奥瑞德关于2016年年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2017-03-17/600666_20170317_4.pdf
1143,2017-03-17,奥瑞德独立董事关于担保事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-17/600666_20170317_5.pdf
1144,2017-03-17,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司重大资产置换及发行股份购买资产并募集配套资金暨关联交易事项之2016年度持续督导意见,/disclosure/listedinfo/announcement/c/2017-03-17/600666_20170317_1.pdf
1145,2017-03-18,奥瑞德关于2016年年度股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2017-03-18/600666_20170318_1.pdf
1146,2017-03-21,奥瑞德关于2016年年度股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2017-03-21/600666_20170321_4.pdf
1147,2017-03-21,奥瑞德：新时代证券股份有限公司关于奥瑞德光电股份有限公司重大资产购买之标的资产2016年度业绩承诺实现情况的核查意见,/disclosure/listedinfo/announcement/c/2017-03-21/600666_20170321_1.pdf
1148,2017-03-21,奥瑞德：新时代证券股份有限公司关于奥瑞德光电股份有限公司重大资产购买之2016年度持续督导工作报告暨持续督导总结报告,/disclosure/listedinfo/announcement/c/2017-03-21/600666_20170321_2.pdf
1149,2017-03-21,奥瑞德：大华会计师事务所关于江西新航科技有限公司重大资产购买业绩承诺实现情况说明的审核报告,/disclosure/listedinfo/announcement/c/2017-03-21/600666_20170321_3.pdf
1150,2017-03-23,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-03-23/600666_20170323_1.pdf
1151,2017-03-23,奥瑞德2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-03-23/600666_20170323_2.pdf
1152,2017-03-25,奥瑞德关于控股股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2017-03-25/600666_20170325_1.pdf
1153,2017-03-30,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-03-30/600666_20170330_1.pdf
1154,2017-03-30,奥瑞德2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-03-30/600666_20170330_2.pdf
1155,2017-03-30,奥瑞德2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-03-30/600666_20170330_3.pdf
1156,2017-04-12,奥瑞德债务融资工具信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_8.pdf
1157,2017-04-12,奥瑞德关于召开2017年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_7.pdf
1158,2017-04-12,奥瑞德关于全资子公司向全资孙公司增资的公告,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_6.pdf
1159,2017-04-12,奥瑞德关于全资子公司拟申请银行贷款暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_2.pdf
1160,2017-04-12,奥瑞德关于拟申请注册发行中期票据的公告,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_4.pdf
1161,2017-04-12,奥瑞德关于拟申请注册发行超短期融资券的公告,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_5.pdf
1162,2017-04-12,奥瑞德关于公司及下属公司拟申请银行授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_3.pdf
1163,2017-04-12,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_9.pdf
1164,2017-04-12,奥瑞德第八届董事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-12/600666_20170412_1.pdf
1165,2017-04-14,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-04-14/600666_20170414_1.pdf
1166,2017-04-14,奥瑞德关于公司股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2017-04-14/600666_20170414_3.pdf
1167,2017-04-14,奥瑞德关于2017年第四次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2017-04-14/600666_20170414_2.pdf
1168,2017-04-15,奥瑞德关于闲置自有资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2017-04-15/600666_20170415_1.pdf
1169,2017-04-19,奥瑞德2017年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-04-19/600666_20170419_1.pdf
1170,2017-04-22,奥瑞德关于中止公司非公开发行股票申请文件审核的公告,/disclosure/listedinfo/announcement/c/2017-04-22/600666_20170422_1.pdf
1171,2017-04-28,奥瑞德关于股票停牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-04-28/600666_20170428_1.pdf
1172,2017-04-28,奥瑞德2017年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-04-28/600666_20170428_2.pdf
1173,2017-04-28,奥瑞德2017年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-28/600666_20170428_3.pdf
1174,2017-04-29,奥瑞德关于全资孙公司完成工商变更的公告,/disclosure/listedinfo/announcement/c/2017-04-29/600666_20170429_2.pdf
1175,2017-04-29,奥瑞德2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-29/600666_2017_1.pdf
1176,2017-05-05,奥瑞德关于全资孙公司完成工商变更的公告,/disclosure/listedinfo/announcement/c/2017-05-05/600666_20170505_1.pdf
1177,2017-05-10,奥瑞德关于收到上海证券交易所对公司2016年年报事后审核及媒体质疑澄清公告相关事项问询函暨公司股票继续停牌的公告,/disclosure/listedinfo/announcement/c/2017-05-10/600666_20170510_2.pdf
1178,2017-05-10,奥瑞德关于媒体报道澄清的公告,/disclosure/listedinfo/announcement/c/2017-05-10/600666_20170510_1.pdf
1179,2017-05-12,奥瑞德关于子公司拟向实际控制人申请借款的关联交易公告,/disclosure/listedinfo/announcement/c/2017-05-12/600666_20170512_2.pdf
1180,2017-05-12,奥瑞德关于召开2017年第五次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-12/600666_20170512_5.pdf
1181,2017-05-12,奥瑞德独立董事关于子公司拟向实际控制人申请借款的关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2017-05-12/600666_20170512_3.pdf
1182,2017-05-12,奥瑞德董事会审计委员会关于全资子公司向实际控制人借款事项的书面核查意见,/disclosure/listedinfo/announcement/c/2017-05-12/600666_20170512_4.pdf
1183,2017-05-12,奥瑞德第八届董事会第三十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-12/600666_20170512_1.pdf
1184,2017-05-17,奥瑞德关于延期回复上海证券交易所问询函暨股票继续停牌的公告,/disclosure/listedinfo/announcement/c/2017-05-17/600666_20170517_1.pdf
1185,2017-05-22,奥瑞德2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-05-22/600666_20170522_1.pdf
1186,2017-05-23,奥瑞德关于全资子公司拟接受委托贷款暨公司及实际控制人提供担保的关联交易议案,/disclosure/listedinfo/announcement/c/2017-05-23/600666_20170523_1.pdf
1187,2017-05-23,奥瑞德关于2017年第五次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2017-05-23/600666_20170523_4.pdf
1188,2017-05-23,奥瑞德独立董事关于全资子公司拟接受委托贷款暨公司及实际控制人提供担保的关联交易事项之事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-05-23/600666_20170523_2.pdf
1189,2017-05-23,奥瑞德董事会审计委员会关于全资子公司拟接受委托贷款暨公司及实际控制人提供担保的关联交易事项之书面核查意见,/disclosure/listedinfo/announcement/c/2017-05-23/600666_20170523_3.pdf
1190,2017-05-24,奥瑞德2017年第五次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-24/600666_20170524_1.pdf
1191,2017-06-02,奥瑞德关于子公司完成工商注销的公告,/disclosure/listedinfo/announcement/c/2017-06-02/600666_20170602_1.pdf
1192,2017-06-02,奥瑞德2017年第五次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-02/600666_20170602_2.pdf
1193,2017-06-02,奥瑞德2017年第五次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-02/600666_20170602_3.pdf
1194,2017-06-10,奥瑞德重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2017-06-10/600666_20170610_1.pdf
1195,2017-06-10,奥瑞德关于上海证券交易所对公司2016年年报事后审核及媒体质疑澄清公告相关事项问询函回复的公告,/disclosure/listedinfo/announcement/c/2017-06-10/600666_20170610_2.pdf
1196,2017-06-10,奥瑞德：新时代证券股份有限公司关于上海证券交易所《关于对奥瑞德光电股份有限公司2016年年报事后审核及媒体质疑澄清公告相关事项的问询函》之专项核实意见,/disclosure/listedinfo/announcement/c/2017-06-10/600666_20170610_5.pdf
1197,2017-06-10,奥瑞德：海通证券关于奥瑞德2016年年报事后审核及媒体质疑澄清公告相关事项的问询函的核查报告,/disclosure/listedinfo/announcement/c/2017-06-10/600666_20170610_4.pdf
1198,2017-06-10,奥瑞德：大华会计师事务所（特殊普通合伙）关于奥瑞德光电股份有限公司2016年年报事后审核及媒体质疑澄清公告问询函的反馈回复（大华核字[2017]002681号）,/disclosure/listedinfo/announcement/c/2017-06-10/600666_20170610_3.pdf
1199,2017-06-14,奥瑞德关于公司前十名股东情况的公告,/disclosure/listedinfo/announcement/c/2017-06-14/600666_20170614_1.pdf
1200,2017-06-17,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-06-17/600666_20170617_1.pdf
1201,2017-06-21,奥瑞德股东减持股份计划实施情况公告,/disclosure/listedinfo/announcement/c/2017-06-21/600666_20170621_1.pdf
1202,2017-06-24,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-06-24/600666_20170624_1.pdf
1203,2017-06-28,奥瑞德信息披露暂缓与豁免业务管理制度,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_2.pdf
1204,2017-06-28,奥瑞德关于召开2017年第六次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_8.pdf
1205,2017-06-28,奥瑞德关于全资子公司拟办理银行授信暨公司及实际控制人提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_3.pdf
1206,2017-06-28,奥瑞德关于变更注册资本及修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_6.pdf
1207,2017-06-28,奥瑞德公司章程（2017年6月修订）,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_7.pdf
1208,2017-06-28,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_4.pdf
1209,2017-06-28,奥瑞德董事会审计委员会关于相关事项的书面核查意见,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_5.pdf
1210,2017-06-28,奥瑞德第八届董事会第三十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-28/600666_20170628_1.pdf
1211,2017-07-01,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-07-01/600666_20170701_1.pdf
1212,2017-07-01,奥瑞德关于全资子公司收到政府奖励补助的提示性公告,/disclosure/listedinfo/announcement/c/2017-07-01/600666_20170701_2.pdf
1213,2017-07-06,奥瑞德2017年第六次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-07-06/600666_20170706_1.pdf
1214,2017-07-08,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-07-08/600666_20170708_1.pdf
1215,2017-07-12,奥瑞德重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2017-07-12/600666_20170712_1.pdf
1216,2017-07-14,奥瑞德2017年第六次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-07-14/600666_20170714_1.pdf
1217,2017-07-14,奥瑞德2017年第六次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-07-14/600666_20170714_2.pdf
1218,2017-07-18,奥瑞德关于实际控制人暨控股股东增持公司股份计划实施结果的公告,/disclosure/listedinfo/announcement/c/2017-07-18/600666_20170718_1.pdf
1219,2017-07-19,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-07-19/600666_20170719_1.pdf
1220,2017-07-26,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-07-26/600666_20170726_1.pdf
1221,2017-08-02,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-08-02/600666_20170802_1.pdf
1222,2017-08-09,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-08-09/600666_20170809_1.pdf
1223,2017-08-12,奥瑞德审议重大资产重组继续停牌的董事会决议公告,/disclosure/listedinfo/announcement/c/2017-08-12/600666_20170812_1.pdf
1224,2017-08-17,奥瑞德关于实际控制人暨控股股东增持公司股份计划延期的公告,/disclosure/listedinfo/announcement/c/2017-08-17/600666_20170817_1.pdf
1225,2017-08-19,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-08-19/600666_20170819_1.pdf
1226,2017-08-23,奥瑞德关于重大资产重组部分限售股上市流通的提示性公告,/disclosure/listedinfo/announcement/c/2017-08-23/600666_20170823_1.pdf
1227,2017-08-23,奥瑞德：海通证券股份有限公司关于奥瑞德光电股份有限公司重大资产重组部分限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2017-08-23/600666_20170823_2.pdf
1228,2017-08-25,奥瑞德关于召开2017年第七次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-08-25/600666_20170825_7.pdf
1229,2017-08-25,奥瑞德独立董事关于公司重大资产重组继续停牌的独立意见,/disclosure/listedinfo/announcement/c/2017-08-25/600666_20170825_4.pdf
1230,2017-08-25,奥瑞德第八届监事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-25/600666_20170825_5.pdf
1231,2017-08-25,奥瑞德第八届董事会第三十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-25/600666_20170825_3.pdf
1232,2017-08-25,奥瑞德2017年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-25/600666_20170825_6.pdf
1233,2017-08-25,奥瑞德2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-25/600666_2017_zzy.pdf
1234,2017-08-25,奥瑞德2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-25/600666_2017_z.pdf
1235,2017-08-26,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-08-26/600666_20170826_1.pdf
1236,2017-09-01,奥瑞德2017年第七次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-09-01/600666_20170901_1.pdf
1237,2017-09-02,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-09-02/600666_20170902_1.pdf
1238,2017-09-05,奥瑞德关于召开重大资产重组投资者说明会的公告,/disclosure/listedinfo/announcement/c/2017-09-05/600666_20170905_1.pdf
1239,2017-09-09,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-09-09/600666_20170909_2.pdf
1240,2017-09-09,奥瑞德关于重大资产重组投资者说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2017-09-09/600666_20170909_1.pdf
1241,2017-09-12,奥瑞德重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2017-09-12/600666_20170912_3.pdf
1242,2017-09-12,奥瑞德独立董事关于公司重大资产重组继续停牌原因符合相关规定的核查意见,/disclosure/listedinfo/announcement/c/2017-09-12/600666_20170912_4.pdf
1243,2017-09-12,奥瑞德：摩根士丹利华鑫证券有限责任公司关于奥瑞德光电股份有限公司重大资产重组延期复牌的核查意见,/disclosure/listedinfo/announcement/c/2017-09-12/600666_20170912_5.pdf
1244,2017-09-12,奥瑞德2017年第七次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-09-12/600666_20170912_1.pdf
1245,2017-09-12,奥瑞德2017年第七次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-09-12/600666_20170912_2.pdf
1246,2017-09-13,奥瑞德关于公司股东部分股权解除质押的公告,/disclosure/listedinfo/announcement/c/2017-09-13/600666_20170913_1.pdf
1247,2017-09-16,奥瑞德关于召开终止2016年度非公开发行A股股票事项投资者说明会的公告,/disclosure/listedinfo/announcement/c/2017-09-16/600666_20170916_2.pdf
1248,2017-09-16,奥瑞德关于公司2016年度非公开发行股票方案到期失效暨终止非公开发行股票并决定撤回相关申报材料的公告,/disclosure/listedinfo/announcement/c/2017-09-16/600666_20170916_1.pdf
1249,2017-09-19,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-09-19/600666_20170919_5.pdf
1250,2017-09-19,奥瑞德关于签署重大资产重组交易框架协议的公告,/disclosure/listedinfo/announcement/c/2017-09-19/600666_20170919_2.pdf
1251,2017-09-19,奥瑞德关于公司拟为全资孙公司提供担保的公告,/disclosure/listedinfo/announcement/c/2017-09-19/600666_20170919_3.pdf
1252,2017-09-19,奥瑞德独立董事关于公司第八届董事会第三十七次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-09-19/600666_20170919_4.pdf
1253,2017-09-19,奥瑞德第八届董事会第三十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-09-19/600666_20170919_1.pdf
1254,2017-09-20,奥瑞德关于终止2016年度非公开发行A股股票事项投资者说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2017-09-20/600666_20170920_1.pdf
1255,2017-09-23,奥瑞德关于变更重大资产重组持续督导期之独立财务顾问主办人的公告,/disclosure/listedinfo/announcement/c/2017-09-23/600666_20170923_1.pdf
1256,2017-09-26,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-09-26/600666_20170926_1.pdf
1257,2017-10-10,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-10-10/600666_20171010_1.pdf
1258,2017-10-10,奥瑞德关于监事会主席辞职的公告,/disclosure/listedinfo/announcement/c/2017-10-10/600666_20171010_2.pdf
1259,2017-10-12,奥瑞德重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2017-10-12/600666_20171012_1.pdf
1260,2017-10-12,奥瑞德：摩根士丹利华鑫证券有限责任公司关于奥瑞德光电股份有限公司重大资产重组停牌期间重组进展信息披露的真实性、继续停牌的合理性和五个月内复牌可行性的核查意见,/disclosure/listedinfo/announcement/c/2017-10-12/600666_20171012_2.pdf
1261,2017-10-17,奥瑞德关于收到《中国证监会行政许可申请终止审查通知书》的公告,/disclosure/listedinfo/announcement/c/2017-10-17/600666_20171017_1.pdf
1262,2017-10-19,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-10-19/600666_20171019_1.pdf
1263,2017-10-25,奥瑞德关于召开2017年第八次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-10-25/600666_20171025_8.pdf
1264,2017-10-25,奥瑞德关于下属公司拟申请银行授信暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-10-25/600666_20171025_5.pdf
1265,2017-10-25,奥瑞德关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-10-25/600666_20171025_7.pdf
1266,2017-10-25,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-10-25/600666_20171025_6.pdf
1267,2017-10-25,奥瑞德第八届监事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-25/600666_20171025_4.pdf
1268,2017-10-25,奥瑞德第八届董事会第三十八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-25/600666_20171025_3.pdf
1269,2017-10-25,奥瑞德2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-25/600666_2017_3.pdf
1270,2017-10-26,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-10-26/600666_20171026_1.pdf
1271,2017-11-01,奥瑞德2017年第八次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-11-01/600666_20171101_1.pdf
1272,2017-11-02,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-02/600666_20171102_1.pdf
1273,2017-11-09,奥瑞德重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2017-11-09/600666_20171109_1.pdf
1274,2017-11-09,奥瑞德关于公司控股股东股权质押的公告,/disclosure/listedinfo/announcement/c/2017-11-09/600666_20171109_2.pdf
1275,2017-11-10,奥瑞德关于选举监事会主席的公告,/disclosure/listedinfo/announcement/c/2017-11-10/600666_20171110_3.pdf
1276,2017-11-10,奥瑞德2017年第八次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-11-10/600666_20171110_1.pdf
1277,2017-11-10,奥瑞德2017年第八次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-11-10/600666_20171110_2.pdf
1278,2017-11-11,奥瑞德关于延期披露重大资产重组预案暨继续停牌公告,/disclosure/listedinfo/announcement/c/2017-11-11/600666_20171111_1.pdf
1279,2017-11-18,奥瑞德关于终止重大资产重组事项召开投资者说明会的公告,/disclosure/listedinfo/announcement/c/2017-11-18/600666_20171118_3.pdf
1280,2017-11-18,奥瑞德关于终止本次重大资产重组的公告,/disclosure/listedinfo/announcement/c/2017-11-18/600666_20171118_1.pdf
1281,2017-11-18,奥瑞德第八届董事会第三十九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-18/600666_20171118_2.pdf
1282,2017-11-21,奥瑞德关于取消召开投资者说明会的公告,/disclosure/listedinfo/announcement/c/2017-11-21/600666_20171121_1.pdf
1283,2017-11-22,奥瑞德关于继续停牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-11-22/600666_20171122_1.pdf
1284,2017-11-23,奥瑞德关于披露重大资产重组预案暨公司股票暂不复牌的公告,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_11.pdf
1285,2017-11-23,奥瑞德关于本次交易不构成重组上市的情况说明,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_7.pdf
1286,2017-11-23,奥瑞德发行股份购买资产并募集配套资金暨关联交易预案摘要,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_1.pdf
1287,2017-11-23,奥瑞德发行股份购买资产并募集配套资金暨关联交易预案,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_2.pdf
1288,2017-11-23,奥瑞德独立董事关于重大资产重组暨关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_3.pdf
1289,2017-11-23,奥瑞德独立董事关于公司第八届董事会第四十次会议审议事项的独立意见,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_6.pdf
1290,2017-11-23,奥瑞德董事会关于停牌前股票价格波动未达到《关于规范上市公司信息披露及相关各方行为的通知》第五条相关标准的说明,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_5.pdf
1291,2017-11-23,奥瑞德第八届监事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_10.pdf
1292,2017-11-23,奥瑞德第八届董事会第四十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_9.pdf
1293,2017-11-23,奥瑞德：摩根士丹利华鑫证券有限责任公司关于奥瑞德光电股份有限公司股票价格波动是否达到《关于规范上市公司信息披露及相关各方行为的通知》第五条相关标准的说明之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_8.pdf
1294,2017-11-23,奥瑞德：摩根士丹利华鑫证券有限责任公司关于奥瑞德光电股份有限公司发行股份购买资产并募集配套资金暨关联交易预案之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2017-11-23/600666_20171123_4.pdf
1295,2017-11-25,奥瑞德关于全资子公司拟申请融资额度暨公司提供担保的公告,/disclosure/listedinfo/announcement/c/2017-11-25/600666_20171125_1.pdf
1296,2017-11-25,奥瑞德关于参加“2017年重庆辖区上市公司投资者网上集体接待日活动”的公告,/disclosure/listedinfo/announcement/c/2017-11-25/600666_20171125_3.pdf
1297,2017-11-25,奥瑞德独立董事关于全资子公司拟申请融资额度暨公司提供担保事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-11-25/600666_20171125_2.pdf
1298,2017-12-06,奥瑞德关于收到上海证券交易所《关于奥瑞德光电股份有限公司发行股份购买资产并募集配套资金暨关联交易预案信息披露的问询函》的公告,/disclosure/listedinfo/announcement/c/2017-12-06/600666_20171206_1.pdf
1299,2017-12-09,奥瑞德关于子公司向实际控制人申请借款的关联交易公告,/disclosure/listedinfo/announcement/c/2017-12-09/600666_20171209_2.pdf
1300,2017-12-09,奥瑞德关于召开2017年第九次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-09/600666_20171209_5.pdf
1301,2017-12-09,奥瑞德关于全资子公司贷款展期暨公司及实际控制人提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2017-12-09/600666_20171209_4.pdf
1302,2017-12-09,奥瑞德独立董事关于相关事项的事前认可及独立意见,/disclosure/listedinfo/announcement/c/2017-12-09/600666_20171209_3.pdf
1303,2017-12-09,奥瑞德第八届董事会第四十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-09/600666_20171209_1.pdf
1304,2017-12-13,奥瑞德关于延期回复上海证券交易所《问询函》暨公司股票继续停牌的公告,/disclosure/listedinfo/announcement/c/2017-12-13/600666_20171213_1.pdf
1305,2017-12-13,奥瑞德关于全资子公司贷款展期暨公司及实际控制人提供担保关联交易的补充公告,/disclosure/listedinfo/announcement/c/2017-12-13/600666_20171213_2.pdf
1306,2017-12-16,奥瑞德2017年第九次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-16/600666_20171216_1.pdf
1307,2017-12-20,奥瑞德关于延期回复上海证券交易所《问询函》暨公司股票继续停牌的公告,/disclosure/listedinfo/announcement/c/2017-12-20/600666_20171220_1.pdf
1308,2017-12-26,奥瑞德关于延期回复上海证券交易所《问询函》事项的进展公告,/disclosure/listedinfo/announcement/c/2017-12-26/600666_20171226_3.pdf
1309,2017-12-26,奥瑞德2017年第九次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-26/600666_20171226_1.pdf
1310,2017-12-26,奥瑞德2017年第九次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-12-26/600666_20171226_2.pdf
1311,2017-12-30,奥瑞德关于召开重大资产重组媒体说明会的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_13.pdf
1312,2017-12-30,奥瑞德关于上海证券交易所关于奥瑞德光电股份有限公司发行股份购买资产并募集配套资金暨关联交易预案信息披露的问询函之回复公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_14.pdf
1313,2017-12-30,奥瑞德关于披露重大资产重组预案（修订稿）及回复上海证券交易所《问询函》暨公司股票暂不复牌的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_1.pdf
1314,2017-12-30,奥瑞德关于公司董事会秘书辞职及聘用高管人员的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_2.pdf
1315,2017-12-30,奥瑞德关于发行股份及支付现金购买资产并募集配套资金暨关联交易预案修订说明的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_5.pdf
1316,2017-12-30,奥瑞德关于本次发行股份及支付现金购买资产并募集配套资金暨关联交易方案调整的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_3.pdf
1317,2017-12-30,奥瑞德发行股份及支付现金购买资产并募集配套资金暨关联交易预案（修订稿）摘要,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_10.pdf
1318,2017-12-30,奥瑞德发行股份及支付现金购买资产并募集配套资金暨关联交易预案（修订稿）,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_11.pdf
1319,2017-12-30,奥瑞德独立董事关于重大资产重组暨关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_8.pdf
1320,2017-12-30,奥瑞德独立董事关于公司第八届董事会第四十三次会议的独立意见,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_7.pdf
1321,2017-12-30,奥瑞德第八届监事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_9.pdf
1322,2017-12-30,奥瑞德第八届董事会第四十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_6.pdf
1323,2017-12-30,奥瑞德：摩根士丹利华鑫证券有限责任公司关于奥瑞德光电股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易方案调整构成重组方案重大调整之核查意见,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_4.pdf
1324,2017-12-30,奥瑞德：摩根士丹利华鑫证券有限责任公司关于《奥瑞德光电股份有限公司对上海证券交易所关于奥瑞德光电股份有限公司发行股份购买资产并募集配套资金暨关联交易预案信息披露的问询函之回复》之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_15.pdf
1325,2017-12-30,奥瑞德：北京市金杜律师事务所关于奥瑞德光电股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易之专项核查意见书,/disclosure/listedinfo/announcement/c/2017-12-30/600666_20171230_12.pdf
1326,2018-01-04,奥瑞德关于收到上海证券交易所《关于对奥瑞德光电股份有限公司发行股份购买资产并募集配套资金暨关联交易预案信息披露的二次问询函》的公告,/disclosure/listedinfo/announcement/c/2018-01-04/600666_20180104_1.pdf
1327,2018-01-06,奥瑞德关于重大资产重组媒体说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2018-01-06/600666_20180106_1.pdf
1328,2018-01-10,奥瑞德关于延期回复上海证券交易所《二次问询函》的公告,/disclosure/listedinfo/announcement/c/2018-01-10/600666_20180110_1.pdf
1329,2018-01-31,奥瑞德2017年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2018-01-31/600666_20180131_1.pdf
1330,2018-02-09,奥瑞德关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2018-02-09/600666_20180209_6.pdf
1331,2018-02-09,奥瑞德关于下属公司申请贷款暨实际控制人及公司提供担保的关联交易公告,/disclosure/listedinfo/announcement/c/2018-02-09/600666_20180209_2.pdf
1332,2018-02-09,奥瑞德关于聘任董事会秘书及增加指定信息披露媒体的公告,/disclosure/listedinfo/announcement/c/2018-02-09/600666_20180209_5.pdf
1333,2018-02-09,奥瑞德独立董事事前认可及独立意见,/disclosure/listedinfo/announcement/c/2018-02-09/600666_20180209_3.pdf
1334,2018-02-09,奥瑞德董事会审计委员会关于下属公司申请贷款暨实际控制人及公司提供担保的关联交易之书面意见,/disclosure/listedinfo/announcement/c/2018-02-09/600666_20180209_4.pdf
1335,2018-02-09,奥瑞德第八届董事会第四十四次会议决议公告,/disclosure/listedinfo/announcement/c/2018-02-09/600666_20180209_1.pdf
